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 Microorganisms occupy almost every habitat on earth such as soils, ocean, 
freshwater, and engineered systems (e.g., wastewater treatment systems), and are often 
associated with other multicellular organisms. Their communities play various important 
roles in controlling the biogeochemical cycles, and human and animal wellbeing (e.g., 
food fermentation, preventing infectious disease agents). Even though the great majority 
of microorganisms are beneficial to human and animal life and health, there have been 
rising public health concerns such as the recent emergence and spreading of antimicrobial 
resistant pathogens.  
 The advent of high-throughput sequencing technology and the accompanying 
development of bioinformatics tools for the analysis of the resulting sequence data in the 
past decade have enabled the high throughput characterization of the complex microbiota 
in various environments. Rapid analysis of microbial isolate genomes from various 
environments through whole-genome sequencing (WGS) has provided new insights into 
their ecological roles, identified novel species, and tracked the source of disease 
outbreaks (1, 2). For example, the identification of genomic islands (GIs) and single 
nucleotide polymorphisms (SNPs) among genomes of the same species can be used to 
identify the genomic determinants of antimicrobial resistance and to distinguish highly 
virulent from commensal strains of the species (3-5). Moreover, the rise of metagenomics 
(sequencing of the total microbial community DNA extracted from a target sample) has 
transformed our understanding of the microbial ecology and physiology of diverse 
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ecosystems, by bypassing the need to isolate the organisms in the lab, a major limitation 
of traditional lab-based approaches (2, 6, 7).  
 Although a substantial amount of work has been done in public and 
environmental health microbiology with omics techniques, there are still unresolved or 
debatable issues remaining. In this thesis, we combined traditional, culture-based 
laboratory techniques with cutting-edge, culture-independent omics tools to provide 
insight into several important research questions. Specifically, in chapter 2, we did 
metagenomic analysis of bioreactors, MinION-based long-read sequencing of microbial 
isolates, and molecular cloning to provide molecular evidence that exposure to the widely 
used disinfectant benzalkonium chlorides (BAC), a member of QAC family, can co-
select for antibiotic resistant bacteria. These results contribute toward solving a high 
debatable issue in the literature for the past two decades, i.e., whether or not exposure to 
disinfectants promotes antibiotic resistance. In chapter 3, we assessed the effects of 
BAC-exposure of two different Pseudomonas aeruginosa strains, i.e., one pre-exposed to 
sub-inhibitory concentrations of BAC for three years vs. its non-exposed counterpart, to 
increasing concentrations of BAC for about two hundred generations (1-2 months) and 
applied transcriptomic analysis to reveal molecular mechanisms for the microbial BAC 
resistance at the whole cell level, including BAC-degradation by microbial enzymes. This 
work also identified microbial taxa and genes to BACs in non-target environments such 
as natural sediments and freshwater ecosystems. Finally, in chapter 4, we applied whole 
community DNA (metagenome) sequencing to 122 stool samples from young children in 
a low-income, urban neighborhood setting in Maputo, Mozambique, to assess the effect 
of shared, on-site sanitation intervention on bacterial gut infections. Our findings 
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suggested that the intervention induce small but significant differences in abundance of at 
least several microbial species, including Veillonella parvula, an opportunistic pathogen. 
However, pathogen load remain high in children with intervention compared to their 




CHAPTER 1 INTRODUCTION 
 
1.1 Microbial cross-resistance between disinfectants and antibiotics 
 The effects of antimicrobial resistance are already seen across the world. 
Excessive use of antibiotics and increased intercontinental travel nowadays have 
accelerated the spreading of antibiotic resistance pathogens worldwide, which leads to 
millions of casualties annually (8, 9). It is estimated that a continued rise in antimicrobial 
resistance by 2050 will lead to the death of 10 million people every year and a reduction 
of 2% to 3.5 % in Gross Domestic Product (GDP), which translates to up to 100 trillion 
USD (9). Even the proper and conservative use of antimicrobials contributes to the 
emergence of resistance, but widespread and excessive use aggravates the resistance 
problems. While the improper use of antibiotics is known to be the primary cause of the 
spreading of antibiotic resistance, excessive use of disinfectants such as quaternary 
ammonium compounds (QAC) can also contribute to the antibiotic resistance problem 
(10, 11). Antibiotics have a specific mode of action that typically differs from those of 
disinfectants such as QAC, which have non-specific and multiple target mode of actions. 
For this reason, QAC are thought to be functionally distinct from antibiotics, which 
implies the absence of cross-resistance between QAC and antibiotics.  
 Consistent with these interpretations, several studies reported the absence of 
cross-resistance between QAC and antibiotics in environmental, clinical, and industrial 
isolates. Further, some of these studies reported that disinfectant resistant pathogens 
showed decreased antibiotic resistance (12-16). For example, a previous study collected a 
total of 1238 isolates, including Staphylococcus aureus, Klebsiella pneumonia, 
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Escherichia coli, and Enterococcus sp. from both antibacterial users and nonusers, and 
provided evidence for the lack of cross-resistance between antibiotic and disinfectants 
(e.g., triclosan and QAC) in all tested bacteria (12). Also, both QAC resistant and non-
resistant isolates of Listeria monocytogenes from an Iberian pig slaughterhouse and 
processing plant showed uniform susceptibility to 12 commonly prescribed antibiotics 
(15).  
 In contrast, several other studies have reported the presence of cross-resistance 
between disinfectants and antibiotics (4, 17-22). For example, sublethal concentrations of 
three widely used disinfectants, including QAC, caused Salmonella enterica serovar 
Typhimurium strain SL1344 to show fourfold-reduced susceptibility to ciprofloxacin, 
chloramphenicol, tetracycline, and ampicillin. Changes in protein expression such as 
ArcAB-TolC efflux pump and lipopolysaccharide O-antigens were implicated as the 
underlying causes for the decreased susceptibility (17). Another study reported that L. 
monocytogenes fed with 10 µg/ml of benzalkonium chlorides (BAC), a prominent 
member of the QAC family, showed increased minimum inhibitory concentrations 
(MICs) for ciprofloxacin, gentamicin, the dye ethidium bromide, and the 
chemotherapeutic drug tetraphenylphosphonium chloride (18). However, the issue of 
disinfectant-induced antibiotic resistance has remained highly debated because most, if 
not all, studies reporting the presence of the cross-resistance have not provided 
convincing evidence for the underlying molecular mechanisms for the reported linkage.  
 In chapter 2, using an integrated approach that combined metagenomics of 
natural microbial communities with gene cloning experiments and experimental 
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evolution assays of isolates, we show that the widely used BAC disinfectants can 
promote clinically-relevant antibiotic resistance.   
1.2 Mechanisms of microbial BAC resistance 
 Benzalkonium chlorides (BAC) are the most commonly used members of 
quaternary ammonium compounds (QAC) disinfectants. BAC are cationic surfactant 
agents due to their amphiphilic property (charged nitrogen atom in the center of the 
molecule with long n-alkyl chain (C8 to C18)). Thus, BAC have broad-spectrum biocidal 
activity (e.g., microbial, algal, fungal, and viral) and remain stable for both short and 
long-term usage (23). Accordingly, BAC are widely used as biocides in disinfectant 
solutions, food processing lines, domestic households, and healthcare facilities (24). Due 
to their wide use and mode of action, there has been rising concern that BAC may 
promote antibiotic resistance. Consistently, at least 40 outbreaks have been attributed to 
infection by disinfectant- and antibiotic-resistant pathogens such as Pseudomonas 
aeruginosa (25-35). Therefore, elucidating microbial BAC resistance mechanisms is 
important for monitoring and restricting the spreading of disinfectant-resistant pathogens. 
 The reported BAC resistance mechanisms include biodegradation by enzymes 
encoded in the genome of specific bacteria, overexpression of efflux pumps, reduction of 
the uptake or adsorption of BAC via downregulation of porins or cell surface 
modifications. Various kinds of efflux pumps have been associated with decreased 
susceptibility to BACs in phylogenetically diverse microorganisms. One such case is the 
multidrug resistance (MdfA) protein in E. coli (36). E. coli cells expressing MdfA are not 
only more resistant to a diverse group of cationic compounds including BAC, but also 
more resistant to clinically important antibiotics such as chloramphenicol and 
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erythromycin. QacA and QacB multidrug efflux pumps from the bacterial pathogen 
Staphylococcus aureus have been also shown to confer resistance to BAC and various 
toxic organic cations (37). Another example is the RND-type multidrug efflux pump 
MexAB-OprM. mexAB-oprM-deficient mutants of the plant pathogen P. syringae showed 
reduced tolerance to a broad range of antimicrobials such as BAC (38). Because the 
mode of actions of BAC involves the disruption of the cell membrane or cell wall (39), 
modifications of microbial cell surface have been hypothesized to be beneficial to BAC 
resistance. For example, BAC adapted Salmonella enterica serovar Enteritids showed a 
higher survival rate as biofilms compared to planktonic cells. Also, these BAC adapted 
cells showed greater cell surface roughness and a shift in cellular fatty acid compositions 
(e.g., phospholipids) (40). 
 The above-mentioned studies revealed several potentially important mechanisms 
and phenotypic characteristics of BAC resistant bacteria. However, the relative 
importance of these mechanisms for BAC resistance, at the whole-cell level, remain 
poorly understood. For instance, it is not clear whether or not all previously identified 
mechanisms are active/relevant for microbial communities that withstand high 
concentration of BACs or a few of them are quantitatively more important than others. 
Further, it is not clear if bacteria can biodegrade BAC by the production of catabolic 
enzymes. We previously described a microbial community degrading BACs under 
aerobic conditions, and we were able to isolate a key member (Pseudomonas 
nitroreducens) and identify its key biodegradation gene (i.e., amine oxidase) that is 
responsible for the BAC dealkylation, resulting in the 500 times reduction of BAC 
toxicity (41). Subsequently, another study identified a different biodegradation gene 
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cassette (42). Thus, it appears that BAC biodegradation is a major mechanism to tolerate 
high concentrations of BAC and the genetic markers to monitor biodegradation have 
recently become available. In chapter 3, using an integrated approach that combined 
genomics and transcriptomics with physiological characterizations of BAC-adapted 
isolates, we provided a comprehensive understanding of the BAC-resistance mechanisms 
in Pseudomonas aeruginosa, an important opportunistic pathogen of respiratory and 
other systems. Our findings also revealed potential genetic markers to detect and monitor 
the abundance of BAC-resistant pathogens across clinical or environmental settings. 
1.3 Poor sanitation in undeveloped countries and its impacts on human health  
 The Joint Monitoring Program (JMP) funded by WHO and UNICEF estimated 
that only 68% of the world’s populations live with improved sanitation (“basic” or 
“safely-managed” sanitation), providing the safe containment and separation of excreta 
from human contact to reduce public health risk (43). In contrast, 32% of humans without 
improved sanitation are exposed to environmental fecal contamination in the household 
or public settings, especially in urban areas of low-income countries with high population 
density (44-48). In low-income countries, urban infrastructure (i.e., improved sanitation) 
has not expanded to serve the needs of newly emerging populations. For instance, urban 
sanitation coverage has only increased from 37% to 47% in the poorest countries from 
1990 to 2015 despite a much larger increase of the relative proportion of urban vs. rural 
populations in these countries (49). In sub-Saharan Africa (SSA), 921 million people still 
lack basic water and sanitation services (50), and, in particular, Mozambique showed one 
of the lowest coverage of sanitation services in the region (49). 
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 The gut microbiota plays an important role in human health (51). For instance, the 
gut microbiota extracts nutrients from the food (52, 53), contributes to regular immune 
function (54), and prevents infections on enteric pathogens (55, 56). The composition of 
gut microbiota in early age is different from that of an adult. While one study reported 
that the age-affiliated gut microbiota changes from 3 days to 2 years after birth with 
major similarities between 2 years and adulthood (57), other studies have suggested that 
gut bacterial communities evolve into adult-like bacterial communities for up to 3 to 4 
years after birth (53, 58) or even that gut microbiota is not yet established at 5 years of 
age (59). As the gut microbiota at an early age is more dynamic and variable compared to 
those of adults (60), it can also influence human host health in more profound ways; for 
example, via contributions to the maturation of the immune system in early days of life 
(61, 62). Furthermore, abnormal changes of the gut microbial community due to infection 
by enteric pathogens or prevalence/spreading of antibiotic resistance genes (ARGs) in the 
gut microbiome of infant/children could have long-term consequences for host health 
(63).  
 Unsafe Water, Sanitation, and Hygiene (WASH) conditions can facilitate the 
transmission of enteric pathogens among the residents through either direct contact or 
acquisition from the environment (64). The spreading of enteric pathogens often results 
in enteric infections that cause diarrheal diseases predominantly among the children and 
may contribute to chronic inflammation in the gut (65, 66). Children who experience 
chronic inflammation of their gut will suffer from serious health problems such as 
reduced absorption of nutrients (67, 68), environmental enteric dysfunction (EED) (69), 
growth faltering and cognitive deficits (70-72), stunting (73), and even death (74). While 
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sanitation interventions are generally believed to promote the reduction of enteric 
infections and the incidence of diarrhea in poor countries (75-80), other studies have 
shown no evidence of significant sanitation intervention effects on health (81-84). 
Insufficient coverage and use of improved latrines, difficulties in changing defecation 
behaviors, and a lack of proper waste management systems (e.g., sewerage systems), are 
thought to be the causes for the absence of effect. Furthermore, the majority of WASH 
studies have employed traditional protocols such as culture, microscopy, and PCR-related 
to detect the etiological agents (pathogens) of the disease. These methods, however, have 
known limitations (e.g., novel pathogens will be missed and pathogen loose cultivability 
when released in the environment) and could provide false-positive signal (48, 85-88), 
which represent another limitation in assessing the effects of sanitation interventions.  
 Two types of sanitation systems, an off-site and an on-site one, can be installed to 
collect and treat sewage in urban slums (89). Simplified sewerage, which is an off-site 
arrangement, differs from conventional sewerage because it is designed with reduced 
pipe diameters, gradients and depths, and non-compromised design standards such as 
placing sewers away from traffic loads generally under the sidewalks rather than under 
the center of the street to minimize excavation and the cost of pavement restoration (90). 
Simplified sewerage can be used in heavily populated urban slums lacking space for on-
site sanitation (91), and consists of a sewer network and a wastewater treatment system 
(89). A flush toilet connected to a septic tank, which is an on-site arrangement, can also 
be used to collect and treat sewage. It only requires water to transport the waste from the 
pipes to a septic tank for proper storage and anaerobic treatment. Septic tank effluent can 
either be discharged in a soakaway (i.e., a deep hole used for drainage) before infiltration 
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in the ground or into a constructed wetland (89). This technology is suitable and widely 
used in urban slums where there is no off-site sewerage (92, 93).   
 In chapter 4, a controlled before-and-after (CBA) study of an urban sanitation 
intervention in Maputo, Mozambique is described. Specifically, compounds with ≤20 
people were provided a single cabin “Shared Latrine,” and compounds with >20 people 
received a “Communal Sanitation Block” (CSB) with one latrine cabin per 20 people 
residing in the compound (64). The CSB interventions also included facilities such as 
laundry and washing units, rainwater and municipal water storage, and handwashing 
stations. Controls were single-cabin pit latrines (i.e., open defecation) serving a minimum 
of 15 people and a maximum of 20 people so that the size of the control group was 
comparable to that of the sanitation intervention group. Also, the control group was 
enrolled during the recruitment of the sanitation intervention group to avoid having time 
gaps between the two study groups (64). The work described in the chapter 4 employed 
metagenomic whole-community DNA sequencing to  investigate whether or not 
sanitation interventions, especially a shared, on-site sanitation, reduced ea n enteric 
infections and the spreading of ARGs in young children as well as to describe the effects 








CHAPTER 2 WIDELY USED BENZALKONIUM CHLORIDE 
DISINFECTANTS CAN PROMOTE ANTIBIOTIC RESISTANCE 
 
This chapter was published in: 
Minjae Kim, Michael R. Weigand, Seungdae Oh, Janet K. Hatt, Raj Krishnan, Ulas 
Tezel, Spyros G. Pavlostathis, and Konstantinos T. Konstantinidis. Appl. Environ. 
Microbiol. 84.17 (2018): e01201-18.  
2.1 Abstract 
 While misuse of antibiotics has clearly contributed to the emergence and 
proliferation of resistant bacterial pathogens with major health consequences, it remains 
less clear if the widespread use of disinfectants, a different class of biocides than 
antibiotics such as benzalkonium chlorides (BAC), has contributed to this problem. Here, 
we provide evidence that exposure to BAC co-selects for antibiotic-resistant bacteria, and 
describe the underlying genetic mechanisms. BAC-fed bioreactors inoculated with river 
sediment selected for several bacterial taxa, including the opportunistic pathogen 
Pseudomonas aeruginosa, that were more resistant to several antibiotics compared to 
their counterparts in a control (no BAC) bioreactor. Metagenomic analysis of the 
bioreactor microbial communities, confirmed by gene cloning experiments with the 
derived isolates, suggested that integrative and conjugative elements encoding a BAC 
efflux pump together with antibiotic resistance genes were responsible for these results. 
Further, exposure of the P. aeruginosa isolates to increasing concentrations of BAC 
selected for mutations in pmrB (polymyxin resistance) and physiological adaptations that 
contributed to higher tolerance to polymyxin B and other antibiotics. Physiological 
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adaptations included, for example, the overexpression of mexCD-oprJ multidrug efflux 
pump genes when BAC was added in the growth medium at sub-inhibitory 
concentrations. Collectively, our results demonstrated that disinfectants can promote 
antibiotic resistance via several mechanisms, and highlight the need to remediate 
(degrade) disinfectants in non-target environments to further restrain the spread of 
antibiotic resistant bacteria.    
2.2 Introduction 
 While inappropriate prescription to humans and misuse of antibiotics in animal 
feed are thought to be the leading causes of the increased frequency of antibiotic 
resistance observed in recent years, there is an increasing concern that widely-used 
disinfectants such as quaternary ammonium compounds (QAC) have contributed to the 
antibiotic resistance problem (10, 11). However, this issue remains highly debatable 
because disinfectants typically have a different mode of action than antibiotics in order to 
avoid overlap between these two distinct classes of biocides that are used for different 
purposes. Further, previous studies have yet to elucidate the underlying mechanisms for 
the reported linkage between disinfectant-exposure and increased antibiotic resistance (4, 
17-21). For instance, Pseudomonas aeruginosa, an important opportunistic human 
pathogen, acquired a 12-fold increased resistance to disinfectants upon disinfectant 
exposure, which was accompanied with a >200 fold increase in ciprofloxacin resistance 
(4). The increased ciprofloxacin resistance was attributed to specific mutations in the 
gyrA but it remained unclear if the mutations were indeed induced by the disinfectant, 
occurred spontaneously or as a result of the growth conditions. The different mode of 
action and target sites between QAC and ciprofloxacin, and the fact that QAC do not 
target the product of the gyrA gene argue in support of the latter interpretation.  
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 Furthermore, other studies reported that antibiotic and disinfectant cross-
resistance is absent in environmental, clinical, and industrial isolates, and disinfectant-
resistant pathogens often show increased antibiotic susceptibility (12-16). Even the recent 
restriction in the use of triclosan and triclocarban, another family of widely used 
disinfectants in antimicrobial soaps, is not accompanied by consistent evidence on the 
linkage between triclosan exposure and antibiotic resistance (94). For instance, several 
studies reported decreased susceptibility of Escherichia coli to chloramphenicol, 
erythromycin, imipenem, tetracycline, trimethoprim, and other biocides as an effect of 
exposure to sub-lethal concentrations of triclosan (95). However, other studies suggested 
that there is no clear link between increased triclosan tolerance and increased antibiotic 
resistance, and actually found that E. coli with increased triclosan tolerance is more 
sensitive to aminoglycoside antibiotics (96). 
 Benzalkonium chlorides (BAC) are the most commonly used members of the 
QAC family of disinfectants, have broad-spectrum (i.e., bacterial, algal, fungal, and viral) 
biocidal activity, and remain stable for both short and long-term usage (23). 
Consequently, BAC are widely used as surface disinfecting agents in food processing 
lines (e.g., poultry facilities), dairy/agricultural settings, health care facilities, and 
domestic households, and are popular ingredients in over-the-counter cosmetics, hand 
sanitizers, and pharmaceuticals products (24). Therefore, BAC represent ideal molecules 
to study the effect of disinfectant exposure on microbial antibiotic resistance. 
Understanding whether or not exposure of bacteria to BAC may lead to increased 
antibiotic resistance and, if so, what the underlying molecular mechanisms might be, are 
important questions to answer for better regulating the usage of BAC and minimizing 
public risk. 
 To obtain insights into this issue, we exposed a microbial community originating 
from a river sediment inoculum (Calcasieu River, USA) to BAC for three years in three 
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aerobic fed-batch bioreactors: dextrin/peptone plus BAC (DPB bioreactor), 
dextrin/peptone (DP bioreactor), or BAC only (B bioreactor) as the main carbon and 
energy sources, as described previously (19, 97). This river is heavily contaminated with 
metals, polycyclic aromatic hydrocarbons and chlorinated/halogenated organic 
compounds. Therefore, its sediment represented an ideal inoculum for our purposes to 
identify organisms with resistance to BAC and other organics since BACs typically 
accumulate in non-target sediments and anoxic habitats (although the exact inoculum 
used in the bioreactors did not contain detectable concentrations of BAC at the time of 
sampling (97). Three years of BAC exposure led to significant changes in the 
composition of microbial communities compared to a control community (DP) under the 
same laboratory conditions (Figure S1A). The BAC exposure also selected for efficient 
degraders of BAC, which we reported previously together with the identification of a 
novel BAC-degrading gene cassette (98). Here we focused on the effects of BAC-
exposure on antibiotic resistance. We also assessed the effects of BAC-exposure on 
shorter time scales by exposing isolates from the control (DP) and DPB bioreactors to 
BAC for about two hundred generations or less (1-2 months).   
2.3 Materials and methods 
2.3.1 Bioreactor development, and isolate characterization  
All microbial communities (DP, DPB, and B) analyzed in this study originated 
from the same inoculum, from a sediment sample collected at the Bayou dʼInde, a 
tributary of the Calcasieu River, near Lake Charles, LA. The residual concentration of 
BAC in the sediment was less than the detection limit of the colorimetric method, i.e., 1 
ug/g-sediment (99). Community development and bioreactor operation (e.g., substrates, 
feeding cycle, temperature) were described previously in detail (19). Briefly, the DP 
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microbial community was developed from the sediment inoculum with dextrin/peptone 
50:50 (w/w) mixture as carbon and energy sources and maintained for one year. The DP 
community was subsequently used as an inoculum for DPB, which in turn was used as an 
inoculum for B microbial community. DPB and B communities were fed by 
dextrin/peptone plus BAC mixture and BAC mixture as carbon and energy sources, 
respectively. BAC mixture represented a 60:40 mixture of 
benzyldimethyldodecylammonium chloride and benzyldimethyltetradecylammonium 
chloride (C12BDMA-Cl and C14BDMA-Cl, respectively; Sigma-Aldrich). The three 
communities were maintained for four years at room temperature in an aerobic fed-batch 
2-L Pyrex® reactor with a total liquid volume of 1.6L, a residence time of 14 days, and 
the previously described mineral medium plus carbon and energy source (i.e., 2200 mg/L 
of dextrin/peptone and 50 mg/L of BAC mixture). To obtain isolates, a mixed community 
suspension from each bioreactor (DP, DPB, and B) was first diluted and plated on agar 
medium containing dextrin/peptone, salt medium, and 1.5% agar as described previously 
(no neutralizer for BAC was used during isolation or transferring of isolates) (100). 
Taxonomic identification of the isolates was determined based on sequencing their 16S 
rRNA genes. 
2.3.2 Construction of plasmids carrying efflux pump genes 
 Efflux pumps genes found on the integrative and conjugative elements (ICE) were 
cloned from Achromobacter B isolate and these genes were identical, at the nucleotide 
level, to those in P. aeruginosa DPB. The genes, including their native promoters, were 
individually amplified by PCR using primers containing enzyme restriction sites (EcoRI-
BamHI for sugE-A: sugE-A-EcoRI: 5’-ATGCGAATTCCAGATAAAGCCAACCTTCC-
3’ and sugE-A-BamHI: 5’-ATGCGGATCCGACTACGCTACCAATGGAG-3’ and 
sugE-B: sugE-B-EcoRI: 5’-ATGCGAATTCCATTATGGAAAGGGATGGCG-3’ and 
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sugE-B-BamHI: 5’-ATGCGGATCCTTGCTCTTCATAATGGGTCTC-3’ and KpnI-
EcoRI for the ABC transporter operon: ABC-KpnI: 5’-
ATGCGGTACCGTACTAGCGTCATAGTCACGG-3’ and ABC-EcoRI: 5’-
ATGCGAATTCCAACGTCATTAAAGAGTTCGC-3’). Digested amplicons were 
ligated into the multiple cloning site of pBBRMCS-4 (101). The resulting constructs were 
introduced into P. aeruginosa-PAO509, which was deficient for several RND-family 
efflux pump genes (mexAB-oprM, mexCD-oprJ, mexEF-oprN, mexJK, and mexXY) (102), 
by electroporation as described previously (103). Transformants were selected on LB 
agar medium supplemented with 100 µg/mL of ampicillin. Recombinant plasmids 
extracted from transformants were confirmed by PCR-amplification of inserts and 
enzyme restriction digestion. 
2.3.3 Adaptive evolution experiments 
 A single colony of the P. aeruginosa DP and DPB isolates was used as the 
original inoculum for the adaptive evolution experiments. Six test tubes with a range of 
BAC concentration were initially inoculated with 1% aliquot of P. aeruginosa DP and 
DPB culture grown in a 10 ml Luria broth medium (LB) for 24 hours in triplicate at 
35°C, using an orbital shaker at 225rpm (Figure S1B). Subsequently, 1% of the adapted 
population from the tube that showed growth (i.e., ≤ 80% growth reduction) at the tube 
with the highest concentration of BAC was transferred to new medium daily, followed by 
similar rounds of increasing BAC concentrations until no growth was observed in any 
tube [BAC(+) populations]. Minimum inhibitory concentration (MIC) was determined as 
the concentration in which ≥ 80% inhibition in cell growth was observed by OD 600 nm 
values compared to control (no BAC in the medium). A 1% aliquot of inoculum culture 
was used for each MIC measurement. Generation numbers of the cultures were measured 
every 24 hours by counting colony-forming units (CFUs). Inoculum from the tube that 
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showed growth in the highest BAC concentration was subsequently transferred to LB 
[BAC(-) populations], followed by rounds of growth in decreasing BAC concentrations. 
The BAC used for the experiment consisted of a 60:40 mixture of 
benzyldimethyldodecylammonium chloride and benzyldimethyltetradecylammonium 
chloride (C12BDMA-Cl and C14BDMA-Cl, respectively; Sigma-Aldrich).  
2.3.4 Antimicrobial susceptibility test 
The antimicrobial susceptibility test was performed with the microdilution 
procedure (104) in LB medium. All tested inocula were sampled at the end of the 
exponential phase and diluted in the medium to a final concentration of 5 × 105 CFU/mL 
before the test. Specifically, we characterized the growth curve for all the tested isolates, 
populations, and transformants with optical density values at 600 nm, and sampled at the 
end of exponential phase to measure CFU and optical density values at 625nm for 10-fold 
serially diluted aliquots (i.e., 10-1, 10-2, and 10-3). Based on these data, the relationship 
between expected CFU and optical density values at 600 nm was determined, and this 
relationship was used to obtain aliquots of 5 × 105 CFU/mL based on the optical density 
values. Therefore, comparable inocula in terms of starting cell numbers were used in all 
cases. All tests were performed in triplicate on 48-well plates after growth of the 
inoculum (5 × 105 CFU/mL) for 24 hours at 35°C while mixed using an orbital shaker at 
225 rpm. After incubation, the optical density values at 600nm were measured and the 
MIC was determined based on the control cultures with LB only medium for LB + 
antibiotics tests and LB+BAC medium for LB + BAC + antibiotics tests.  
2.3.5 DNA extraction, RNA extraction and sequencing 
 Mixed community suspensions from bioreactors and isolates were taken for DNA 
extraction and processed as previously described (105). These DNA samples were 
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sequenced using the Illumina HiSeq 2000 sequencer at the Los Alamos National 
Laboratory Genomics Facility and reported previously (105); the ancestor P. aeruginosa 
DPB genome was closed using data from an in-house MinION instrument and the 
Illumina assembly. DNA of all P. aeruginosa populations from adaptive evolution 
experiments was extracted using the QIAamp DNA Blood Mini kit (Qiagen, Germany). 
DNA sequencing libraries were prepared using the Nextera XT DNA library prep and 
sequenced on an in-house Illumina MiSeq instrument (School of Biological Sciences, 
Georgia Institute of Technology) as described previously (106).  
 RNA of P. aeruginosa DPB populations from the adaptive evolution experiment 
was extracted as previously described (107) with slight modifications. In brief, culture 
suspensions (25 mL of LB culture, and 50 mL of LB+BAC culture) were collected during 
mid-log phase growth and centrifuged at 5000 x g for 10 minutes. BAC (1000 mg/L) was 
used in the growth medium for all DPB BAC(+) and BAC(-)_2 populations, and 100 mg 
of BAC/L was used for the ancestor, control, and BAC(-)_1 populations, which 
represented sub-inhibitory concentrations for the corresponding populations. The 
collected cell pellet was subsequently washed with 1X PBS, and re-suspended with 5 mL 
of lysis buffer (50 mM Tris-HCl, 40 mM EDTA ph 8, and 0.75 M sucrose) containing 15 
mg/mL of lysozyme, and incubated at 37°C for 3 min. The lysates were then incubated 
with 0.4 mL of the lysis buffer, containing 1% SDS and 20 mg/mL of proteinase K, for 2 
hours at 55°C in a rotating hybridization oven. RNA was extracted with acid phenol and 
chloroform and isolated by mirVANA RNA isolation kit (Ambion). RNA samples were 
treated with DNase using the TURBO DNA-free kit (Ambion, Austin, TX). Elimination 
of contaminating DNA was confirmed by PCR amplification of the sugE-A gene. 
Ribosomal RNA (rRNA) was depleted from total RNA using the Ribo-Zero rRNA 
Removal Kit (Illumina, San Diego, CA) and cDNA libraries were constructed using the 
ScriptSeq v2 RNA-Seq Library Preparation Kit (Illumina, San Diego, CA) according to 
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manufacturer’s instructions. cDNA libraries were quantified and sequenced as described 
above for P. aeruginosa population DNA samples. 
2.3.6 Community metagenome and isolate genome sequence analysis 
 Raw Illumina reads were trimmed using a Q=15 PHRED quality score cutoff 
using SolexaQA(108) for further analysis. Community and isolate genome reads were 
assembled using the hybrid protocol previously described (109). Protein-coding genes 
encoded on assembled metagenomic or isolate genome contigs were annotated with the 
MetaGene pipeline (110). The phylogenetic affiliation of assembled contigs or 
unassembled metagenomic reads were determined based on best match searches against 
all bacterial and archaeal genome sequences available in GenBank database (as of June 
2015, ftp://ftp.ncbi.nih.gov/), using Blastn (X = 150, q = -1, and F = F, remaining 
parameters at default settings) with a cutoff of a match with >95% identity and 50% 
query length coverage. The functional annotation of protein-coding genes was performed 
using a Blastp search against the SEED protein database (111), with a cutoff for a match 
of  >40% amino acid sequence identity and >50% query length coverage.  
 We used Bowtie 2 (112) to map metagenomic reads from DPB bioreactor against 
P. aeruginosa DPB assembled contigs to estimate coverage, which was also taken as a 
proxy for relative abundance. To identify SNPs and genomic modifications, P. aerginosa 
DP genomic reads were matched against P. aeruginosa DPB assembled contigs, and vice 
versa using breseq (consensus mode and Q=15 PHRED quality score cutoff were used) 
(113, 114). The same approach was also applied in comparisons of P. aeruginosa DP and 
DPB control, BAC(+), and BAC(-) populations against P. aeruginosa DP and DPB 
assembled contigs (ancestors) in the adaptive evolution experiments. Identified mutations 
in the evolved control population against its ancestor were considered to be the result of 
stochastic processes or selection by the growth conditions (e.g., “bottle effect”), and were 
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removed from further analysis. Read recruitment plots were obtained as described 
previously (115) based on the results of a Blastn search of reads against the GI-2 
sequence of P. aeruginosa DPB and a minimum cut-off for a match of 70% of identity 
and 60 bp alignment length. 
2.3.7 MinION sequencing and read analysis 
 Sequencing libraries for the MinION sequencer were prepared using the SQK - 
RAD003 Rapid Sequencing Kit, R9 version lot SR03.10.002 (Oxford Nanopore 
Technologies, Oxford, United Kingdom). Approximately, 421 ng of P. aeruginosa strain 
DPB DNA was tagmented by incubation with 2.5 µL Fragmentation Mix (FRM) for 1 
min at 30 °C followed by 1 min at 80 °C. Tagmented DNA was then adapter - ligated by 
incubation with 1.0 µL Rapid Adapter mix (RAD) for 5 min at room temperature and 
stored on ice.  A FLO-MIN 107 (R9.5) flow cell was primed as directed by the 
manufacturer and then loaded with a mixture of 11 µL tagmented library, 30.5 µL 
Running Buffer FM (RBF), 26.5 µL Library Loading Beads (LLB) and 7 µL Nuclease-
free water. P. aeruginosa DPB was sequenced using the SQK-RAD003 MinKNOW 
protocol script with local basecalling and the sequencing was stopped after 12 hours.   
 After base-calling of the 1D MinION reads, the reads were extracted in fastq 
format using Poretools version 0.6.0 (116). All resulting reads were trimmed using 
NanoFilt (https://github.com/wdecoster/nanofilt) with a PHRED score cutoff of 10 and a 
minimum fragment length of 1 Kbp, and the adapter sequences were removed using 
Porechop (https://github.com/rrwick/Porechop). Then, the hybrid read set, i.e., Illumina 
and MinION trimmed reads, were assembled using Unicycler v0.4.2 with the 
conservative mode (117). Briefly, Unicycler uses a SPAdes assembly of Illumina reads 
and then scaffolds the assembly graph using MinION reads. Finally, Unicycler uses 
Illumina reads to polish the final assembly using Pilon (118). To identify genomic islands 
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specific to the P. aeruginosa DPB closed genome from the hybrid Illumina+MinION 
assembly, P. aerginosa DP genomic reads (Illumina) were searched against the P. 
aeruginosa DPB genome using breseq (consensus mode and Q=15 PHRED quality score 
cutoff were used) (113, 114) and the genomic regions not covered by reads were 
considered strain DPB-specific. 
2.3.8 Transcriptome sequence analysis  
 All transcriptomic reads of P. aeruginosa DPB ancestor, control population, all 
BAC(+), BAC(-)_1 and BAC(-)_2 populations were trimmed using SolexaQA (108) with 
a PHRED score cutoff of 20 and a minimum fragment length of 50 bp, and 3’-end 
adapter contaminants were removed using Scythe v0.993 
(https://github.com/vsbuffalo/scythe). These trimmed reads were filtered using 
SortMeRNA v2.0(119) to remove remaining rRNA sequences with all databases in the 
program. Most of the resulting datasets had >95% of their total reads to be non-rRNA 
except three libraries (Table A 7). One library (i.e., P. aeruginosa DPB BAC(+)_2L_3) in 
particular showed 9.42% of reads to be non-rRNA which resulted in too few non-rRNA 
sequences relative to the remaining libraries (e.g., >2 fold difference in number of non-
rRNA reads), and thus was removed from further analysis in order to not bias the 
comparisons and results (120). Non-rRNA reads were mapped to P. aeruginosa DPB 
assembled contigs using Bowtie 2 (112) and read count tables against predicted genes 
were generated by featureCounts v1.4.6-p3 (121). The output read count tables were used 
as input for DESeq2 (122) to obtain the lists of differentially expressed genes in pairwise 
comparisons. The pairwise comparisons included both the type of populations (e.g., 
ancestor vs. BAC(+) populations) and culture conditions (i.e., BAC-free vs. BAC-
supplemented). All genes that were differentially expressed from all pairwise 
comparisons with cutoff of padj < 0.01 and number of read counts > 1 were included for 
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further analysis. Differentially expressed genes from the comparison between control 
population and ancestor that were also observed in the comparison of BAC(+) or BAC(-) 
populations against the ancestor were discarded from further analysis, similar to the 
mutations described above.  
2.3.9 Data release  
 The bioreactor metagenome sequences used in this study were deposited in 
GenBank under the accession numbers: SRR643889 (DP), SRR643891 (DPB), and 
SRR643892 (B). The genome sequences of isolates, all genomic and transcriptomic 
sequences of P. aeurginosa DP/DPB BAC(+) and BAC(-) populations, and MinION 
sequencing data can be found under the BioProject PRJNA184698. 
2.4 Results and Discussion 
2.4.1 Microbial community exposure to BAC selected for members with increased 
resistance to antibiotics. 
 To examine whether BAC exposure promoted (i.e., increased) antibiotic 
resistance, pairs of isolates, one originating from the DPB or B (i.e., BAC-fed) bioreactor 
and the other one representing its counterpart (same species) from the DP (i.e, no-BAC-
fed) bioreactor, were characterized for their resistance to representatives of seven classes 
of antibiotics. The isolates represented four distinct species that were relatively abundant 
in the bioreactors and highly represented among the total isolates obtained (Figure A 1). 
P. aeruginosa strain DPB showed higher minimal inhibitory concentration (MIC) values 
for BAC and several, but not all, antibiotics compared to P. aeruginosa strain DP (Table 
2-1). The genomes of these two P. aeruginosa isolates differed in their shared genes by 
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five single nucleotide polymorphisms (SNPs), one small (9 bp) insertion in their shared 
genes and two genomic islands (GIs) (Figure 2-1). This number of mutations was 
comparable to the number of mutations predicted (n= ~10) to be fixed under neutral 
evolution based on the spontaneous mutation rate for a bacterial genome (5.4 × 10-10 per 
base per generation) (123), the genome size of the P. aeruginosa isolates (~6.4 Mb), and 
the estimated number of generations since the establishment of the DPB and DP 
communities after three years (~3,000 generations). Hence, it is highly likely that these 
isolates represented descendants of the same ancestor in the original river sediment 
inoculum. P. aeruginosa can grow in soil, marshes, coastal marine habitats, plants, and 
animal tissues (124) and it is commonly isolated from sediments (125). Therefore, it was 
not surprising to recover P. aeruginosa from our sediment inoculum.  
 Similar antibiotic resistance results to P. aeruginosa isolates were observed for 
Achromobacter sp. strain DPB/B and Achromobacter denitrificans strain DP, which 
represented more divergent genotypes than the P. aeruginosa isolates (genome-aggregate 
average nucleotide identity or ANI between the Achromobacter sp. DPB/B and A. 
denitrificans DP isolates was 87.5%, Table 2-1). In contrast, Citrobacter freundi strain 
DPB and Klebsiella michiganensis strain DPB did not exhibit significant changes in MIC 
values for antibiotics compared to their unexposed counterparts (Table 2-1). However, 
the latter two isolates showed higher MIC values for BAC and several antibiotics 
compared to C. freundii and K. michiganensis isolates from culture collections (type 
strains) or the human gastrointestinal tract, indicating that C. freundii DP and K. 
michiganensis DP might have been intrinsically resistant to several of the antibiotics 
tested here before BAC exposure. Overall, although BAC exposure did not result in 
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higher antibiotic resistance in all isolates tested, at least P. aerugionsa showed reduced 
susceptibility to BAC by 4 fold and three antibiotics from the seven tested including 
ciprofloxacin, chloramphenicol, and rifampicin by 2 fold, suggesting a resistance link 
between BAC and antibiotics. 
 
 
Figure 2-1. Horizontal transfer of antibiotic efflux pump genes. (A) 
Comparison of the draft genomes of P. aeruginosa DPB vs. P. aeruginosa 
DP. Circles represent: contigs (red) of P. aeruginosa DPB and coverage of 
contigs by metagenomic reads of DPB reactor (black), and the P. 
aeruginosa-DP strain (blue). Genes with mutations found between the two 
genomes are denoted on the graph (ticks on the P. aeruginosa DPB draft 
genome). (B) Graphic representation of the organization of genes encoded 
on the ICE recovered from isolate genomes and metagenomes. (C) 
Phylogenetic tree of 16S rRNA gene sequences and ATP-binding gene (of 
the ABC transporter) sequences based on the maximum likelihood 
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phylogenetically diverse isolates shared almost identical (>99% identity) 
ATP- binding gene sequences, suggesting horizontal transfer of the ATP-
binding gene. Similar results were also observed for sugE-A and sugE-B 
genes (data not shown). The reference sequences used were P. aeruginosa-
39016 (accession no. NZ_CM001020.1), P. aeruginosa-NCGM2.S1 









Table 2-1. MIC of BAC and antibiotics for isolates of same species. A range of antibiotic and BAC concentrations 
(0.4 to 3200 mg/L) were tested and the table shows the determined MIC values, 16S rRNA gene sequence identity 
and average nucleotide identity (ANI) against the control isolate of the same or closely related species (denoted by “-
“). C. freundii Human strain was 4_7_47_CFAA, accession no. ADLG00000000.1, of the Human Microbiome 
Project (http://www.hmpdacc.org/) and K. michiganensis type strain was KCTC 1686, accession no. CP003218.1, of 
Korean Collection for Type Cultures. a TET, Tetracycline; CIP, Ciprofloxacin;  CHL, Chloramphenicol; POL, 
Polymyxin B; KAN, Kanamycin; RIF, Rifampicin; AMP, Ampicillin 








BAC TET CIP CHL POL KAN RIF AMP 
Achromobacter denitrificans DP - - 15.6 < 3.1 < 0.8 3.1 < 0.4 100 12.5 200 
Achromobacter sp. DPB 97.8 87.5 31.3 25 1.6 25 < 0.4 25 3.1 < 6.3 
Achromobacter sp. B 97.7 87.5 125 200 12.5 100 3.1 100 12.5 < 6.3 
Citrobacter freundii Human - - < 7.8 1.6 0.4 12.5 0.2 6.3 25 800 
Citrobacter freundii DP 98.5 N/A 62.5 1.6 1.6 12.5 0.8 6.3 25 12.5 
Citrobacter freundii DPB 99.5 94.2 62.5 1.6 0.8 12.5 0.4 6.3 25 25 
Klebsiella michiganensis type - - 15.6 1.6 < 0.1 6.3 1.6 200 12.5 200 
Klebsiella michiganensis DP 99.1 N/A 62.5 1.6 1.6 12.5 0.8 25 12.5 100 
 
 25 
Klebsiella michiganensis DPB 99.9 99.4 62.5 1.6 1.6 12.5 1.6 25 25 100 
Pseudomonas aeruginosa DP - - 50 12.5 0.1 50 0.2 100 12.5 3200 




2.4.2 Genetic elements encoding genes for resistance to both BAC and antibiotics were 
responsible for the link. 
 To investigate the molecular mechanisms responsible for the resistance link, we 
conducted whole isolate and bioreactor metagenome DNA sequencing. Alignment of the 
P. aeruginosa DP genomic reads against the P. aeruginosa DPB assembled contigs 
identified, in addition to the five SNPs and the small insertion mentioned above, two GIs 
that encoded several integrases and transposases (GI-1) together with several (predicted) 
resistance genes (GI-2) (Figure 2-1A). GI-2 harbored four predicted efflux pump 
systems: two small multidrug resistant (SMR) family systems, (sugE-A and sugE-B), an 
ATP-binding cassette (ABC) family, and a resistance nodulation division (RND) family 
member (Figure 2-1B). Furthermore, GI-2 encoded all necessary genes for conjugation 
such as conjugative transfer (trbBCDEJLFGI), plasmid partitioning genes (parAB), 
plasmid replication initiator (repA) in a single assembled Illumina contig. Recruitment of 
Illumina reads from the DPB metagenome revealed that the coverage of GI-2 (Avg. 17.7 
reads/base pair or 17.7X) was significantly higher (P < 0.001, Student’s t-test) than the 
rest of the P. aeruginosa-DPB genome (Avg. 2.0X), indicating that GI-2 was present in 
additional members of the DPB community or in multi-copy (Figure 2-1A). Consistent 
with this interpretation, genome sequence analysis of Achromobacter sp., P. 
nitroreducens, C. freundii, K. michiganensis and P. aeruginosa isolates from DPB or B 
communities revealed an almost identical (>99% nucleotide identity) genetic element 
despite substantial evolutionary divergence of the organisms (Figure 2-1B and Figure 
2-1C). Since GI-2 was the only genomic difference between P. aeruginosa DP and DPB 
strains that was bioinformatically-predicted to encode enzymes potentially relevant for 
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BAC and antibiotic resistance, we hypothesized that GI-2 might have been responsible 
for the higher antibiotic resistance of strain P. aeruginosa DPB relative to strain DP and 
thus, we studied this genomic island in more detail. 
 Even though GI-2 was predicted to encode several of the genes commonly found 
in conjugative plasmids, long-read Oxford Nanopore sequencing showed that the 
conjugative element was integrated in the genome of P. aeruginosa DPB. The hybrid 
assembly of the MinION long reads and Illumina contigs produced a closed genome 
(single contig), with even coverage across the genome, including the junctions/ends of 
the Illumina contig encoding the conjugative transfer genes. Further bioinformatics 
analysis and gene annotation, e.g., presence of recombinase genes (often referred to as 
integrases) and conjugation system genes (Table A 1) (126, 127), suggested that the GI-2 
is most likely an ICE. ICEs share gene content with conjugative plasmids (e.g., genes for 
conjugation), and are self-transmissible genetic elements that can be integrated in the 
chromosome or propagate as independently replicating molecules (See Supporting results 
and discussion for further details) (126, 127). Alignment of genomic reads of other 
isolates, i.e., Achromobacter sp. DPB/B, C. freundii DPB and K. michiganensis DPB, 
against P. aeruginosa DPB GI-2 sequence suggested that not all of the isolates shared the 
whole GI-2 or all integrases, except for Achromobacter sp. DPB (Figure A 2). These 
results revealed that GI-2 has likely been mobilized and/or integrated into diverse 
organisms during bioreactor incubation time (3 years), and various versions of ICEs 
encoding the same resistance genes were present within the community, which were 
apparently strongly selected by the BAC exposure conditions.  
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 To test the hypothesis that GI-2-encoding genes helped organisms to cope with 
BAC toxicity and were responsible for the higher antibiotic resistance of P. aeruginosa 
strain DPB relative to strain DP, the sugE-A, sugE-B, and ABC transporter system genes 
were cloned into a broad-host range vector (pBBRMCS-4) and transformed into P. 
aeruginosa-PAO509. PAO509 lacks several efflux pump systems present in the wild-
type P. aeruginosa and our isolates from the bioreactors and hence, is a more appropriate 
strain background to test for antibiotic resistance phenotypes. Plasmid pBBRsugE-A 
conferred increased resistance to BAC, with a ~2 fold higher MIC, but not antibiotics, 
while plasmid pBBRABC conferred resistance to rifampicin (~2 fold higher MIC) but 
BAC tolerance was similar to the control vector alone (pBBRMCS-4) (Table A 2). It 
should be noted that even a two fold higher MIC can be clinically significant, and efflux 
pumps genes such as sugE-A and ABC do not often provide for much greater changes in 
MIC values (128-131). The BAC-resistance phenotype of the transformant carrying 
sugE-A (PAO509/pBBRsugE-A) was also in agreement with a previous report that sugE 
confers resistance to BAC (132). Rifampicin is known to act on the RNA polymerase β 
subunit (RpoB) to interfere with transcription and rifampicin-resistant bacteria frequently 
emerge due to single point mutations in rpoB (133). To exclude the possibility that the 
rifampicin-resistant phenotype was due to spontaneous mutation (as opposed to the ABC 
transporter system cloned), rpoB gene sequences of Rif clusters I, II, and III were PCR-
amplified from four independent colonies of PAO509 and PAO509/pBBRABC using 
previously determined primers PAO1rpoB1 (134) and PAOrpoB3 (135) and subsequently 
sequenced using Sanger chemistry. No mutation was identified between PAO509 and 
PAO509/pBBRABC, suggesting that the rifampicin resistance phenotype was likely not 
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due to spontaneous mutation but to the ABC transporter system. No difference in 
tetracycline susceptibility was observed in the three recombinants compared to the 
control. These results suggested that two distinct gene cassettes encoded by GI-2 
conferred resistance to antibiotic and BAC respectively, but no one gene conferred 
resistance to both BAC and antibiotics. Therefore the resistance linkages appeared to be 
due to the co-occurrence of these two gene cassettes on the same piece of mobile DNA. It 
still remains unclear at this point if the co-localization of the genes occurred before or 
after exposure to BAC. 
2.4.3 BAC-adaptation selected for P. aeruginosa with increased resistance to 
polymyxin B. 
 To identify alternative genetic mechanisms that may be responsible for the 
resistance linkage observed but were not elucidated by our genetic manipulations, and 
assess the effects of shorter BAC exposure compared to that experienced by the microbial 
communities in the DPB and B bioreactors (~3 years), the two P. aeruginosa isolates DP 
and DPB were subjected to increasingly higher BAC concentrations every 24 hours, in 
triplicate batch cultures, until no growth was observed. The last (highest) concentration 
for which growth was observed was recorded for each replicate population [BAC (+)]. 
Subsequently, the populations were transferred and maintained in BAC-free medium 
[BAC(-); Figure 2-2A, Figure 2-2B, and Figure A 1B]. During this evolution 
experiment, the two genotypes existed on different adaptive landscapes because strain 
DPB possessed the ICE-encoding resistance genes and therefore, was inherently more 
resistant to BAC (Table 2-1). The other pairs of isolates recovered that showed cross-
resistance such as Achromobacter were not used in the adaptive evolution experiment 
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because these experiments were laborious and the pair of genomes recovered were 
divergence from each other (i.e. having different genomic backgrounds), which could 
complicate results and interpretations. 
 All DP and DPB populations showed increased resistance to BAC after growth 
with BAC for about 240 and 180 generations, respectively, compared to their ancestor (7 
to 25 fold higher MIC) or the controls (P. aeruginosa DP or DPB population evolving in 
parallel, under the same laboratory conditions but with no BAC in the growth medium). 
No BAC biodegradation by any of the populations was observed while the highest BAC 
tolerance observed (by DPB population) was 1,600 mg/L BAC. After transfer to BAC-
free medium, the three DP BAC(-) populations lost their BAC tolerance within 150 
generations, and their BAC MIC was similar to that of the ancestor (50 mg/L BAC), 
indicating that adaptation to BAC might have been transient, at the level of cell 
physiology and gene regulation, or due to the rise of compensatory mutations that 
restored sensitivity to BAC under growth in BAC-free medium. In contrast, two of the 
DPB BAC(-) populations maintained high BAC tolerance with MIC for BAC similar to 
those of the BAC(+) populations and about 7 fold higher than that of their ancestor while 
the third DPB BAC(-) population lost the acquired BAC tolerance. These results 
indicated that the two DPB BAC(+) populations might have acquired genetic 
modifications upon BAC exposure that were maintained in their corresponding DPB 
BAC(-) populations. Since all DP and DPB BAC (+) populations, and two of the DPB 
BAC(-) populations acquired increased tolerance to BAC, these populations were 
examined further to assess if the increased BAC tolerance was accompanied by increased 
resistance to antibiotics and the underlying mechanism(s). 
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  Interestingly, we observed that all DP BAC(+) populations showed higher MIC (2 
to 8 fold) to the membrane-active antibiotic polymyxin B compared to the ancestor or the 
control (Table 2-2). Of the remaining antibiotics tested, DP BAC(+) populations did not 
show higher MIC than their ancestor (Table A 3A). To identify the molecular 
mechanisms for cross resistance between BAC and polymyxin B, whole genome 
sequencing was conducted and identified 29 SNPs and 17 DIP (deletions, insertions and 
other polymorphisms) in P. aeruginosa DP BAC(+) and BAC(-) populations relative to 
the control population, and 22 SNPs and 16 DIP in P. aeruginosa DPB BAC(+) and 
BAC(-) populations, respectively (Table A 4A, Table A 4B, Table A 4C and Table A 
4D). Remarkably, all DP BAC(+) and DPB BAC(+) populations had fixed mutations 
compared to their ancestral populations in only a single gene found in common, pmrB, 
albeit at different positions of the gene. pmrAB encodes a two-component regulatory 
system, and mutations in pmrB are known to confer polymyxin resistance in both clinical 
isolates and a laboratory strain of P. aeruginosa via constitutive activation of the pmrA 
regulon (136). Expression of pmrA leads to the expression of arnBCADTEF, which is 
responsible for the addition of 4-amino-L-arabinose (L-Ara4N) to the phosphate groups 
of lipid A, resulting in reduction of net negative charge on the outer membrane (Figure 
2-3B) (137, 138). Because both polymyxin B and BAC are cationic membrane-disrupting 
agents (139, 140), the reduction in net negative charge is expected to increase BAC and 
polymyxin B tolerance by reducing their adsorption to the outer membrane. Therefore, 
our results revealed that mutations to the pmrB gene in the DP BAC(+) populations were 
selected by BAC exposure and led to increased resistance to at least one antibiotic, 
polymyxin B.  
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 It should be noted, that although all the P. aeruginosa populations had fixed 
mutations in pmrB, only the DP BAC(+) populations showed increased resistance to 
polymyxin B compared to the DP BAC(-), DPB BAC(+) and DPB BAC(-) populations 
under our experimental conditions (Figure 2-3A, Table 2-2, and Table A 3B). Read 
alignment of the datasets of DP BAC(-) populations against assembled contigs of the 
ancestors revealed that the populations had different mutations in pmrB and pmrA 
compared to those in DP BAC(+) populations (Table A 5). RNA-seq results suggested 
that the mutations to pmrB in DPB BAC(+) and DPB BAC(-) populations did not lead to 
the overexpression of arnBCADTEF relative to the ancestor and control (See Supporting 
results and discussion for further details). These findings presumably explained the lack 
of increased polymyxin B resistance in the DP BAC(-), DPB BAC(+) and DPB BAC(-) 
populations because the location and combination of mutations in pmrB are known to 
affect the level of expression of arnB (137), as confirmed by our RNA-seq data, and thus, 
polymyxin B resistance. Further, repeated passages without polymyxin in the growth 
media have been shown to result in loss of resistance in some cases, suggesting that the 
pmrAB locus is not the only determinant of the resistance phenotype (137) (See 
Supporting results and discussion for further details). The lack of increased polymyxin 
resistance and the different mutations acquired in the pmrB gene in DPB populations are 
also not surprising given that these populations existed on different adaptive landscapes 
at the beginning of the experiment than DP populations. Altogether, BAC exposure 
selected for the mutations in pmrB that conferred increased BAC-tolerance in all P. 
aeruginosa populations, but only specific mutations conferred increased polymyxin B 





Figure 2-2. Changes in minimal inhibitory concentration (MIC) of BAC during an 
adaptive evolution experiment with P. aeruginosa DP (A) and P. aeruginosa DPB 
(B). The adaptive evolution experiment consisted of two phases; BAC-exposure, where 
BAC concentration was increased after each round until reaching the maximum 
concentration in which growth was observed (red dots; each dot represents a passage), 
and BAC-free (yellow dots). The MIC for BAC (y-axis) was measured during each round 
of growth, for about 320 to 500 generations. The X-axis shows the number of generations 
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Table 2-2. MIC values for polymyxin B of all populations of P. aeruginosa 
DP from the adaptive evolution experiment 
P. aeruginosa 
DP populations  
(LB cultured) 













Table 2-3. MIC values for tetracycline and ciprofloxacin tested with no-










BAC(+)_1 12.5 0.2 25 3.2 
BAC(+)_2 3.125 0.2 12.5 1.6 
BAC(+)_3 12.5 0.2 25 0.8 
Ancestor 6.25 0.2 25 1.6 





Figure 2-3. Mutational and transcriptional evidence for the resistance 
links between BAC and antibiotics. (A) Mutations in pmrB genes at 
various positions were noted for each population (denoted on the graph). 
(B) Schematic of the known polymyxinB resistance mechanisms caused 
by mutations in pmrB gene(136, 138, 141). (C) Overexpression of mexCD-
oprJ operon when BAC is supplemented in the growth media. AL/AB: 
P.aeruginosa DPB ancestor in LB growth media versus LB+BAC media; 
C2L/C2B: P. aeruginosa DPB_Control_2 in LB vs. LB+BAC; 
BAC(+)_1L/BAC(+)_1B: P. aeruginosa DPB BAC(+)_1 in LB vs. 
LB+BAC; BAC(+)_2L/BAC(+)_2B: P. aeruginosa DPB BAC(+)_2 in LB 
vs. LB+BAC; BAC(+)_3L/BAC(+)_3B: P. aeruginosa DPB BAC(+)_3 in 
LB vs. LB+BAC. 
2.4.4 Physiological adaptation to BAC exposure also led to increased antibiotic 
resistance. 
 During this evolution experiment, another important resistance link was revealed. 















DP BAC(+) & 
BAC(-)_3  
(A874G, M292V) 
DP BAC(+) & BAC(-)_1, 





Histidine Kinase A domain  Histidine kinase-like ATPases  
DPB BAC(+) & 
BAC(-)_1 
(T509C, L170P)   
DPB BAC(+) & 
BAC(-)_2 (G25A, 
V9I)   
DPB BAC(+) & BAC(-)_3 























OprJ (gene_4924) MexD (gene_4925) MexC (gene_4926) 
 
 36 
resistance to tetracycline and ciprofloxacin (2 to 16 fold) when BAC was in the growth 
media at sub-inhibitory concentrations during the MIC test (Table 2-3 and Table A 3C). 
All populations tested here reached at least ~107 cells/mL after 24 hours growth at 35°C 
in the presence of sub-inhibitory concentrations of BAC, and these populations were used 
as controls for determining MIC values for antibiotics. Therefore, the sub-inhibitory 
concentration of BAC used did not inhibit growth, and the MIC values obtained were 
presumably not due to experimental artifacts such as absorbance contributed by dead cell 
debris. Thus, it appeared that co-presence of (sub-inhibitory) BAC in the growth medium 
of P. aeruginosa DPB induced physiological changes to the exposed cells that also 
conferred antibiotic resistance regardless of the level of BAC tolerance of the population. 
RNA-seq analysis revealed, for instance, over-expression (6 to 40 fold) of the mexCD-
oprJ multidrug efflux pump (Figure 2-3C) under BAC-supplemented compared to BAC-
free growth conditions. These findings were also consistent with previous results that 
mexCD-oprJ contributes to resistance to several classes of antibiotics such as 
fluoroquinolones (e.g., ciprofloxacin, and norfloxacin) and tetracycline (142, 143). 
Furthermore, previous studies have shown that clinically relevant disinfectants such as 
BAC but not antibiotics (e.g., norfloxacin, tetracycline, or chloramphenicol) can induce 
the expression of this family of efflux pumps even though antibiotics such as tetracycline 
and norfloxacin (in the same class as ciprofloxacin) are substrates for the pump (144, 
145), in agreement with the results reported here.  
2.5 CONCLUSIONS AND OUTLOOK 
 Collectively, our results revealed that BAC exposure can induce antibiotic 
resistance via multiple genetic mechanisms, including co-occurrence of BAC-tolerance 
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and antibiotic resistance genes on the same mobile DNA molecule, mutations in the pmrB 
gene, and induction of efflux pump expression. These results are important because the 
cross-link between BAC exposure and antibiotic resistance was observed in at least three 
antibiotics of the seven tested  (Table 2-1), the underlying mechanisms were elucidated 
(Figure 2-1 and Figure 2-3) so the cross-link can not be attributed to spurious findings, 
and even a two fold higher MIC as revealed for polymyxin B and rifampicin can be 
clinically significant based on the pharmacokinetics and pharmacodynamics of these two 
antibiotics (129, 130). Further, the concentrations of BAC that the adapted P. aeruginosa 
DP BAC(+) and DPB BAC(+) populations were able to withstand during the adaptive 
evolution experiments (up to 1,600 mg/L) were comparable to, or even higher, than those 
used in practice as disinfectant (typically between 400-500 mg/L, and almost always 
below 1,000 mg/L) (146). Therefore, our results suggested that accumulation of BAC in 
any non-target environments (e.g., freshwater or sediments habitats, or the waste stream 
of hospitals or food processing facilities) should be prevented in order to limit the 
spreading of antibiotic resistance determinants. New biotechnologies that employ the 
recently reported BAC-degrading organisms or their enzymes could be used for the latter 
purpose (98, 106). Our results also helped to explain why there is a debate in the 
literature on whether or not linkage exists between exposure to disinfectants and 
increased antibiotic resistance. In particular, multiple adaptive possibilities (e.g., 
mutations in pmrB) in P. aeruginosa isolates were observed in response to BAC 
exposure, which is perhaps not unexpected given the non-specific nature of the 
disinfectant, and some -but not all- of these mutations also conferred benefits under other 
conditions, specifically polymyxin exposure. Similarly, not all bacterial species exposed 
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to BAC acquired increased resistance to antibiotics but at least several did (e.g., P. 
aeruginosa). It is also important to note that the list of organisms or growth conditions 
studied here were, by no means, exhaustive and additional mechanisms, which may cause 
even higher antibiotic resistance levels than what was noted here, likely exist in natural or 
clinical/engineered environments. Therefore, more attention should be given to the usage 
of disinfectant and the better understanding of their fate, especially in non-target 
environments. Finally, our experimental design and approach used in the adaptive 
evolution of P. aeruginosa can be employed to assess whether or not other important 
pathogens also show cross-resistance for BAC and antibiotics, and identify the 
underlying molecular mechanisms. 
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CHAPTER 3 GENOMIC AND TRANSCRIPTOMIC INSIGHTS 
INTO HOW BACTERIA WITHSTAND HIGH 
CONCENTRATIONS OF BENZALKONIUM CHLORIDE 
BIOCIDES 
This chapter was published in: 
Minjae Kim, Janet K. Hatt, Michael R. Weigand, Raj Krishnan, Spyros G. Pavlostathis, 
and Konstantinos T. Konstantinidis. Appl. Environ. Microbiol. 84.12 (2018): e00197-18. 
3.1 Abstract 
 Benzalkonium chlorides (BAC) are commonly used biocides in broad-spectrum 
disinfectant solutions. How microorganisms cope with BAC exposure remains poorly 
understood, despite its importance for disinfection and disinfectant-induced antibiotic 
resistance. To provide insights into these issues, we exposed two isolates of an 
opportunistic pathogen, Pseudomonas aeruginosa, to increasing concentrations of BAC. 
One isolate was pre-adapted to BAC as it originated from a bioreactor fed with sub-
inhibitory concentrations of BAC for 3 years, while the other originated from a bioreactor 
that received no BAC. Replicated populations of both isolates were able to survive high 
concentrations of BAC, up to 1200 and 1600mg/L for the non- and pre-adapted ones, 
respectively, exceeding typical application doses. RNA-seq analysis revealed up-
regulation of efflux pump genes and decreased expression of porins related to BAC 
transport as well as reduced growth rate. Increased expression of spermidine (a 
polycation) synthase genes and mutations in the pmrB (polymyxin resistance) gene, 
which cause a reduction in membrane negative charge, suggested that a major adaptation 
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to exposure to the cationic surfactant BAC was to actively stabilize cell surface charge. 
Collectively, these results revealed that P. aeruginosa adapts to BAC exposure by a 
combination of mechanisms, and provided genetic markers to monitor BAC-resistant 
organisms that may have applications in the practice of disinfection. 
3.2 Introduction 
 Benzalkonium chlorides (BAC) are among the most commonly used members of 
the quaternary ammonium compound (QAC) as biocides. BAC act as cationic surfactants 
due to their amphiphilic property, i.e., positively charged nitrogen atom in the center of a 
molecule with C8 to C18 n-alkyl chain. BAC have broad-spectrum biocidal activity 
against microbial, algal, fungal, and viral organisms, based on the following modes of 
action (23): (i) adsorption and penetration of the BAC into the cell wall; (ii) interaction 
with the cytoplasmic membrane (lipid or protein) followed by membrane disorganization; 
(iii) leakage of intracellular light molecular weight material; (iv) degradation of proteins 
and nucleic acids; and (v) cell wall lysis by activity of autolytic enzymes (147, 148). 
BAC remain stable under various conditions in acidic, alkaline, and oxidative 
environments (149). Accordingly, BAC are widely employed in disinfectant 
solutions/formulations for food processing lines, such as poultry facilities and 
dairy/agricultural settings, health care facilities and domestic households, and are popular 
ingredients for over-the-counter products such as cosmetics, hand sanitizers, and 
pharmaceuticals (24). Their extensive use and stability, especially under sediment-sorbed 
conditions (but not under non-sorbed, aerobic conditions where BAC can be quickly 
biodegraded; see also below), have caused BAC concentrations to often be higher than 
those of other conventional organic pollutants (e.g., polyaromatic hydrocarbons) or other 
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QAC representatives in non-target environments (150, 151). BAC have been detected 
across diverse environments such as river (at concentrations of ~6 µg/kg) and estuarine 
sediments (1.5 µg/kg), surface water (1.9 µg/L), wastewater influent (170 µg/L) and 
hospital wastewater, where they can reach concentrations up to ~6.03 mg/L (150-153).  
 Although BAC disinfectant solutions applied in hospital settings have a pH that is 
neutral to alkaline, are noncorrosive, non-staining, and are considered safe to apply on all 
washable surfaces (154, 155), at least 40 outbreaks have been attributed to infection by 
disinfectant-resistant pathogens contaminating antiseptic products such as Pseudomonas 
aeruginosa (25-33, 35, 156). It has been hypothesized that the contaminating pathogens 
may be associated with the water used in pharmaceutical processing facilities, or the 
storage of BAC with cotton or gauze (35, 157). Thus, a better understanding of how 
microorganisms become resistant to BAC may help to better control such outbreak 
incidents. However, the underlying mechanisms of BAC-resistance and their relative 
importance remain poorly elucidated (157) (see below for details). Furthermore, there is 
rising concern that widely-used disinfectants such as BAC can promote antibiotic 
resistance (4, 17-21). For instance, our previous study revealed that exposure to BAC can 
promote resistance to various antibiotics, including polymyxin B and identified the 
molecular mechanisms for the resistance linkage between BAC and antibiotics (M. Kim, 
M. R. Weigand, S. Oh, J. K. Hatt, R. Krishnan, U. Tezel, S. G. Pavlostathis, and K. T. 
Konstantinidis, unpublished data). Antibiotic resistant infections cause millions of 
casualties annually, emphasizing the need to better understand BAC resistance 
mechanisms that can also contribute to antibiotic resistance (9). 
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 Several studies have reported BAC resistance in phylogenetically diverse 
microorganisms, most often related to the activation of efflux pump genes from four 
families, i.e., the major facilitator superfamily (MFS) (36, 37), the multidrug and toxic 
compound extrusion family (MATE) (158, 159), the resistance nodulation cell division 
family (RND) (160), and the small multidrug resistance family (SMR) (161, 162). In 
addition to efflux pump up-regulation, dealkylation of BAC to benzyl dimethylamine 
(BDMA) and a long alkyl chain represents another important process for the development 
of BAC resistance (biodegradation) because BDMA is about 500 times less toxic than 
BAC (10, 97, 98). Furthermore, several studies have suggested that BAC resistant 
bacteria show cell envelope modifications such as reduced negative charge of the cell 
surface, increased cell surface hydrophobicity, reduced cell surface roughness, and 
increased saturated fatty acids components on the cell surface, probably resulting in the 
decrease of cell membrane permeability and fluidity (40, 163, 164). Because the cell wall 
in Gram-positive bacteria and the outer membrane in Gram-negative bacteria act as 
barriers blocking the entrance and access of BAC to the inner cell membrane, such cell 
surface modifications are expected to be beneficial to BAC resistance. 
 Although the above mentioned studies attempted to link specific phenotypic 
properties such as the active removal of BAC by efflux pumps, and reduction of the 
uptake, adsorption, and permeability of BAC via several types of cell surface 
modifications to BAC resistance, there is a lack of a comprehensive understanding of 
BAC-resistance mechanisms at the whole-cell level, e.g., whether or not a cell employs 
all these mechanisms and their relative importance in coping with high BAC 
concentrations. Further, it remains unclear to what specific mutations are selected by 
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BAC exposure. Such mutations could also serve as biomarkers for detecting BAC-
resistant microorganisms as well. 
 To provide new insights into these questions, we exposed two strains (individual 
colonies) of P. aeruginosa, strains DP and DPB, to increasing concentrations of BAC 
during an adaptive evolution experiment (Fig. 1). DP and DPB strains originated from the 
same ancestor from a river sediment inoculum, but DP was subsequently propagated for 
three years in a fed-batch aerobic bioreactor with a dextrin peptone mix (DP) as a sole 
carbon source and never saw BAC during this incubation period, while DPB originated 
from a bioreactor fed with dextrin peptone plus 50mg/L BAC. Neither of the strains was 
able to degrade BAC in pure culture based on HPLC results; hence, biodegradation was 
excluded as a potential mechanism to cope with BAC exposure in the present study. We 
have previously sequenced the genomes of the two strains in order to evaluate whether or 
not the genetic adaptations, which have occurred under BAC-supplemented vs. BAC-free 
bioreactor conditions, have conferred increased antibiotic resistance. Briefly, we found 
that the two genomes differed by five point mutations, one small (9-bp) insertion, and 
two genomic islands, one of which appeared to be an integrative and conjugative element 
(ICE) likely acquired during growth in the BAC-supplemented bioreactor. At least two 
these genomic changes were selected by BAC exposure and conferred increased 
resistance to a couple antibiotics, which we will report in detail elsewhere (M. Kim, M. 
R. Weigand, S. Oh, J. K. Hatt, R. Krishnan, U. Tezel, S. G. Pavlostathis, and K. T. 
Konstantinidis, unpublished data). Here we focus on cellular adaptation to BAC-exposure 
by investigating mutations occurring in the genome of the two strains with different 
histories of BAC exposure within short periods of time (e.g., 100-200 generations) and 
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under increasing BAC concentrations as well as gene expression differences between 
BAC vs. non-BAC growth conditions.  
3.3 Material and Methods 
3.3.1 Adaptive evolution experiments 
 The BAC used in the experiments described here consisted of a 60:40 mixture of 
benzyldimethyldodecylammonium chloride and benzyldimethyltetradecylammonium 
chloride (C12BDMA-Cl and C14BDMA-Cl, respectively; Sigma-Aldrich). Six test tubes 
containing a range of BAC concentrations (e.g., a range from 200 mg/L BAC to 400 
mg/L BAC) in 10 ml Luria (LB) broth medium were inoculated with a 1% aliquot of P. 
aeruginosa DP or DPB and allowed to grow for 24 hours in triplicate at 35°C, using an 
orbital shaker at 225rpm. The 1% aliquot originated from an overnight culture grown 
from a single colony of each isolate. Subsequently, 1% aliquot of the adapted population 
from the tube among the six tubes that showed growth at the highest minimum inhibitory 
concentration (MIC) was transferred to new six tubes with increasing BAC 
concentrations daily. The process was continued for multiple rounds until no growth was 
observed in any of the six tubes [BAC(+) populations]. Growth was defined as an optical 
density (OD) ratio >0.2 relative to the control culture grown in LB medium (no BAC). 
Inoculum from three BAC(+) populations (replicates) was then transferred to fresh LB 
medium with no BAC added [BAC(-) populations] daily, for about one hundred 
generations (Fig. 1A and 1B). Control experiments were conducted in parallel with the 
same original inoculum (i.e., ancestor strains) but no BAC added in the medium. P. 
aeruginosa DP and DPB control populations (i.e., Control_1 and Control_2) were 
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sampled when BAC(+) and BAC(-) populations were sampled, respectively. The number 
of generations of the cultures was measured every 24 hours by counting colony-forming 
units (CFUs). MIC was determined as the concentration at which ≥ 80% inhibition in cell 
growth was observed by OD 600 nm values compared to control (no BAC in the 
medium). The BAC antimicrobial susceptibility test was performed with the 
microdilution procedure (104) in LB medium. All populations were tested for their ability 
to biodegrade BAC using High Performance Liquid Chromatography (HPLC) as 
described previously (98). 
3.3.2 DNA extraction, RNA extraction, and sequencing 
 DNA of all P. aeruginosa populations from the adaptive evolution experiment 
was extracted using the QIAamp DNA Blood Mini kit (Qiagen, Germany). DNA 
sequencing libraries were prepared using the Nextera XT DNA library prep kit (Illumina, 
San Diego, CA) and were sequenced using an Illumina MiSeq instrument (Georgia 
Institute of Technology). RNA of P. aeruginosa DPB populations from the adaptive 
evolution experiment was extracted as previously described (107). Briefly, cells form 
each P. aeruginosa population grown in LB or LB+BAC medium were harvested during 
mid-log phase, based on OD 600nm measurements. Ribosomal RNA (rRNA) was 
depleted from total RNA using the Ribo-Zero rRNA Removal Kit (Illumina, San Diego, 
CA) and cDNA libraries were constructed using the ScriptSeq v2 RNA-Seq Library 
Preparation Kit (Illumina, San Diego, CA) according to manufacturer’s instructions. All 
constructed cDNA libraries were sequenced using either an Illumina MiSeq instrument or 
an Illumina HiSEQ 2500 instrument at the Georgia Institute of Technology. 
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3.3.3 Bioinformatics sequence analysis 
 DNA of all P. aeruginosa populations from the adaptive evolution experiment 
was extracted using the QIAamp DNA Blood Mini kit (Qiagen, Germany). DNA 
sequencing libraries were prepared using the Nextera XT DNA library prep kit (Illumina, 
San Diego, CA) and were sequenced using an Illumina MiSeq instrument (Georgia 
Institute of Technology). RNA of P. aeruginosa DPB populations from the adaptive 
evolution experiment was extracted as previously described (107). Briefly, cells form 
each P. aeruginosa population grown in LB or LB+BAC medium were harvested during 
mid-log phase, based on OD 600nm measurements. Ribosomal RNA (rRNA) was 
depleted from total RNA using the Ribo-Zero rRNA Removal Kit (Illumina, San Diego, 
CA) and cDNA libraries were constructed using the ScriptSeq v2 RNA-Seq Library 
Preparation Kit (Illumina, San Diego, CA) according to manufacturer’s instructions. All 
constructed cDNA libraries were sequenced using either an Illumina MiSeq instrument or 
an Illumina HiSEQ 2500 instrument at the Georgia Institute of Technology. 
3.3.4 Growth of P. aeruginosa DPB ancestor and BAC(+) populations at sub-inhibitory 
concentrations of BAC 
 To assess growth characteristics of populations, i.e., λ, lag time; and µ, maximal 
growth rate, the following experiment was performed. The growth medium contained 
sub-inhibitory concentrations of BAC, which were 100 mg/L BAC and 1000 mg/L BAC 
for the ancestor and BAC(+) populations, respectively. All tested inocula were first 
grown in LB growth media and sampled at the end of the exponential phase in order to be 
subsequently inoculated (diluted) in the abovementioned BAC-supplemented media to a 
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final concentration of 5 × 105 CFU/mL. Cell growth was performed in four replicates on 
24-well plates and was measured at 600 nm using a spectrophotometer. Lag time (λ) and 
maximal growth rate (µ) were estimated by fitting the data with the spline fit in the grofit 
R package (165). 
3.3.5 Data release 
 The isolate genome sequences were deposited at DDBJ/ENA/GenBank under the 
accession numbers:  MTLL00000000 (P. aeruginosa DP) and MTLM00000000 (P. 
aeruginosa DPB), and all genomic and transcriptomic sequences of P. aeurginosa DPB 
BAC(+) and BAC(-) populations can be found under the BioProject PRJNA184698. 
3.4 Results and Discussion 
3.4.1 Resistance levels of P. aeruginosa exposed to increasing BAC concentrations 
 The initial BAC minimum inhibitory concentration (MIC) for P. aeruginosa DP 
and P. aeruginosa DPB was 50 mg/L BAC and 240 mg/L BAC, respectively, (Figure 
3-1A) consistent with their history of BAC exposure and accumulated genomic 
modifications, i.e., presence of an ICE encoding a BAC efflux pump (i.e., sugE-A) in P. 
aeruginosa DPB and lack of the ICE in P. aeruginosa DP (see also gene expression 
results below). For the adaptive evolution experiment (Figure 3-1), six test tubes 
containing a range of BAC concentrations (e.g., a range from 200 mg/L BAC to 400 
mg/L BAC) in Luria broth (LB) medium were inoculated with a 1% aliquot of a P. 
aeruginosa DP or DPB overnight culture and allowed to grow for 24 hours in triplicate. 
Subsequently, 1% aliquot of the adapted population from the tube among the six tubes 
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that showed growth at the highest minimum inhibitory concentration (MIC) was 
transferred to new six tubes with increasing BAC concentrations daily. The process was 
continued for multiple rounds until no growth was observed in any of the six tubes 
[BAC(+) populations]. All P. aeruginosa DP BAC(+) populations showed increased MIC 
for BAC after growth under increasing BAC concentrations for approximately 240 
generations (DP BAC(+)_1: 920 mg/L BAC, DP BAC(+)_2: 1240 mg/L BAC, and DP 
BAC(+)_3: 520 mg/L BAC). P. aeruginosa DPB BAC(+) populations showed even 
higher MIC for BAC after growth with BAC for about 180 generations (DPB BAC(+)_1: 
1640 mg/L BAC, DP BAC(+)_2: 1560 mg/L BAC, and DP BAC(+)_3: 1640 mg/L BAC). 
No biodegradation of BAC was observed by any of the populations, indicating that the 
BAC resistance mechanisms were physiological (e.g. differential gene expression) and/or 
genetic (DNA mutations).  
 P. aeruginosa DP and DPB BAC(+) populations were let to evolve in LB only 
(no BAC added) after they reached the maximum BAC concentration that they were able 
to withstand [thereafter referred to as BAC(-) populations; Figure 3-1] in order to test 
how quickly the BAC-resistance phenotype could be lost (or not). Interestingly, while all 
three P. aeruginosa DP BAC(-) populations reverted back to the similar level of the 
initial MIC (50 mg/L BAC) within 150 generations after transfer to BAC-free medium, 
two of the P. aeruginosa DPB BAC(-) populations maintained high BAC resistance with 
MIC for BAC similar to those of the DPB BAC(+) populations. The third P. aeruginosa 
DPB BAC(-) lost BAC tolerance with MIC for BAC reverting to the initial MIC (240 
mg/L BAC) within about 140 generations of transferring to BAC-free medium, similar to 
the results observed for DP BAC(-) populations. These observed phenotypic differences 
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called for further genomic and transcriptomic investigations to elucidate the molecular 
mechanisms for BAC resistance employed by the adapted populations. 
 
Figure 3-1.  Schematic graphs of the adaptive evolution experiment. (A) 
Changes in minimum inhibitory concentration (MIC) of BAC. Each 
adaptive evolution experiment is divided into two phases; BAC-exposure, 
where BAC concentration was increased after each round until reaching 
the maximum BAC concentration in which growth was observed. And, a 
BAC-free phase, where BAC was removed from the growth media. Red 
and blue lines represent P. aeruginosa DPB and P. aeruginosa DP 
populations, respectively. (B) A schematic representation of the 
experimental design. 1% of aliquot from the culture that showed higher 
than 0.2 relative growth ratio compared to the control (measured by 
optical density; yellow test tubes) for the highest concentration of BAC 
tested was used as inoculum (bold black mark the inoculum tube for the 
example shown) for the next round with higher BAC concentrations. Red 
tubes represent no growth. 
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3.4.2 Fixed mutations in only a single gene pmrB in all BAC-adapted populations 
 Whole genome sequencing identified 29 SNPs and 17 DIPs (deletions, insertions 
and other polymorphisms) in P. aeruginosa DP BAC(+) and BAC(-) populations, and 22 
SNPs and 16 DIPs in P. aeruginosa DPB BAC(+) and BAC(-) populations relative to the 
control population and the ancestor, respectively (Table B 1A, Table B 1B, Table B 1C, 
and Table B 1D). Several additional mutations identified in all P. aeruginosa DP and 
DPB populations showed lower frequencies (range: 50-80%) and were excluded from 
further analysis in order to focus on fixed mutations, which are more likely to underlie 
adaption. Based on the number of fixed mutations, the estimated spontaneous mutation 
rate was 6.49 × 10-9 mutations per base per generation for P. aeruginosa DP BAC(+) 
populations, which was higher (3.85-fold, P = 0.016, Student’s t-test) than that of the P. 
aeruginosa DP BAC(-) populations (1.68 × 10-9 mutations per base per generation). On 
the other hand, the estimated spontaneous mutation rate for P. aeruginosa DPB BAC(+) 
populations was 7.34-fold higher than that of the P. aeruginosa DPB BAC(-) populations 
(7.72 × 10-9 vs. 1.05 × 10-9), which was significant (P < 0.01, Student’s t-test). Therefore, 
higher mutation rates were observed during BAC-adaptation compared to growth on 
BAC-free medium for both P. aeruginosa isolates, and the change in mutation rate was 
higher for DPB populations, which withstood higher BAC concentrations.  
 Notably, all DP BAC(+)/BAC(-) and DPB BAC(+)/BAC(-) had fixed mutations 
only in a single gene in common, pmrB, albeit at different locations within the gene. 
Mutations in pmrB are known to confer polymyxin antibiotic resistance and the level of 
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polymyxin antibiotic resistance depends on the type of mutation in pmrB (e.g., location 
and combinations of mutation) (137). Apparently, these mutations were selected by BAC 
exposure and represent a common mechanism to cope with BAC toxicity, at least for P. 
aeruginosa (Note that polymixin is also a membrane-disrupting agent, similar to BAC) 
(139, 140). In particular, mutations in pmrB are known to lead to constitutive activation 
of the pmrA regulon, and expression of pmrA leads to the expression of arnBCADTEF, 
which is responsible for the addition of 4-amino-L-arabinose (L-Ara4N) to the phosphate 
groups of lipid A, resulting in reduction of the net negative charge on the outer membrane 
(136-138). The reduction in net negative charge could increase bacterial BAC tolerance 
by reducing adsorption of the positively-charged BAC molecules to the cell wall.  
 The loss of BAC resistance in DP BAC(-) populations was attributable to the 
acquisition of different mutations in other parts of pmrAB or other regulatory genes 
selected by BAC(-) growth conditions (Table B 1C and Table B 1E). In particular, P. 
aeruginosa DP BAC(-)_2 and DP BAC(-)_3 subpopulations had additional mutations at 
different locations in pmrB and pmrA compared to those in P. aeruginosa DP BAC(+) 
populations (e.g., SNPs in pmrB in >50% of the population), and P. aeruginosa DP 
BAC(-)_1 had a 15bp insertion mutation in the quorum sensing regulator gene lasR, 
which controls more than 300 genes including various efflux pump genes (e.g., MFS, and 
RND family) (166, 167) (Table B 1C). These results may explain the loss of BAC 
resistance in all DP BAC(-) populations, although direct experimental verification of 
these results will be subject of future research.  
 Other than pmrB, no consistent mutations were identified in a functional gene that 
was shared by all of the triplicate populations of either DP or DPB strains. The latter 
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findings indicated that additional adaptations to BAC exposure might have been at the 
level of cell physiology and/or gene regulation. Therefore, we conducted transcriptomic 
analysis for P. aeruginosa DPB BAC(+) and BAC(-) populations both under BAC-free 
and sub-inhibitory BAC concentrations in order to identify molecular mechanisms for 
BAC adaptation. 
 
3.4.3 Gene expression under BAC-exposed conditions 
 To further investigate the molecular mechanisms for BAC resistance in P. 
aeruginosa DPB, we first conducted pairwise comparisons of gene expression profiles 
determined by RNA-seq of the ancestral population and its evolved control population 
(under BAC-free medium, LB) of P. aeruginosa DPB when grown with BAC-free versus 
BAC-exposed media (i.e., sub-inhibitory concentration of BAC were used). These 
pairwise comparisons identified 1071 differentially expressed genes in the ancestor and 
1474 differentially expressed genes in the control out of the total 6038 predicted genes 
present in the genome (Table B 2). Notably, expression of efflux pump genes (i.e., sugE-
A, sugE-B, ATP-binding cassette (ABC) family, and a resistance nodulation division 
(RND) family member) in the ICE increased in both the ancestral and control populations 
under the BAC-exposed vs. BAC-free conditions (Figure 3-2). The expression level of 
sugE-A, in particular, was slightly increased in the ancestor (1.4 fold higher), but not 
statistically significantly (padj > 0.01), and increased significantly in the control 
population (4 fold higher with padj < 0.01) under BAC-exposed conditions. sugE-A has 
also been shown previously to confer increased BAC resistance in Enterobacter cloacae 
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(132). Collectively, these results suggested that the ICE conferred BAC-resistance based 
on the presence of sugE-A and other transport proteins.  
 Furthermore, three protein sequences of the ICE encode for a RND transporter 
that showed > 95% amino acid sequence identity with the AcrAB-TolC efflux pump in 
Salmonella enterica subsp. enterica serovar Typhimurium, except for AcrA, which 
showed 25% amino acid sequence identity. BAC resistance mutants of S. Typhimurium 
showed increased expression of arcB and deletion mutants for acrAB and tolC showed 
increased susceptibility to BAC (168). Similar to the sugE-A genes mentioned above, the 
ancestor showed slightly increased, but not significant, expression of acrB and tolC (1.7 
and 2.3 fold higher, with padj > 0.01, respectively), and the control population showed 
significantly increased expression of all these genes (Figure 3-2). These results suggested 
that the efflux pump genes might also be responsible, at least in part, for BAC resistance.  
 Further, the different degrees of overexpression of these genes under BAC-
exposed conditions in the control and the ancestor population compared to the BAC-free 
conditions maybe be attributable to the exposure history of the populations. The control 
grew for ~330 generations in LB medium before the MIC for BAC test was performed, 
while the ancestor experienced growth for ~3 years in a BAC-amended bioreactor before 
the test. Thus, the ancestor was perhaps (more) pre-adapted to BAC presence, which 
likely accounted, at least in part, for lower induction of the efflux pump genes in the ICE 
relative to BAC-free conditions. Consistent with this explanation, background ICE gene 
expression in the ancestor was higher, by 2.8 fold, on average than that in the control 
under BAC-free conditions (P < 0.01, Student’s t-test), but no such significant difference 
was observed under BAC-exposed conditions. It is also important to note that the ICE 
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was likely present in the highly complex microbial community of the starting river 
sediment inoculum given that P. aeruginosa DPB, who encoded the ICE, and DP isolates 
represented descendants of the same ancestor in the original inoculum based on sequence 
analysis (e.g., it is less likely that the ICE element was brought into the bioreactors 
through aerial transport in the meanwhile). However, the exact genomic context that the 
ICE resided in the original inoculum remains unknown.  
 In order to further corroborate these findings, and provide insights into the 
specific adaptations that enable evolved P. aeruginosa DPB strains to withstand high 
concentrations of BAC, we conducted pairwise comparisons of gene expression between 
the ancestral population and the P. aeruginosa DPB BAC(+) populations, under both 
BAC-free (Table B 3 and Table B 4) and BAC-exposed conditions (Table B 5 and Table 
B 6). Differentially expressed genes in the evolved control population versus the ancestor 
were considered to be the result of stochastic processes or selection by the growth 
conditions (e.g., “bottle effect”), and these genes were removed from the comparison of 
the ancestor versus the P. aeruginosa DPB BAC(+) as also performed in several previous 
studies, e.g., (169). In the pairwise comparison between the ancestor and P. aeruginosa 
DPB BAC(+) populations under BAC-exposed conditions, we were able to identify 303 
differentially expressed genes that were shared among the three P. aeruginosa DPB 
BAC(+) populations (Table B 5), while 381, 272 and 710  differentially expressed genes 
were specific to P. aeruginosa DPB BAC(+)_1, P. aeruginosa DPB BAC(+)_2, and P. 
aeruginosa DPB BAC(+)_3, respectively (Table B 6). This number of genes was 
significantly larger the one form a similar comparison under BAC-free condition 
(identified 61 differentially expressed genes in common), indicating that important 
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physiological adaptations to BAC exposure have taken place in the replicate P. 
aeruginosa DPB BAC(+) populations and underlay their (shared) high MIC levels for 
BAC. Consistent with the latter interpretations, the total number of differentially 
expressed genes (n=373) found in the comparison between P. aeurginosa DPB 
BAC(+)_1 and P. aeurginosa DPB BAC(-)_1, which lost BAC resistance, under BAC-
exposed conditions was higher than the number of such genes (n=16) found in the 
comparison between P. aeruginosa DPB BAC(+)_2 and P. aeruginosa DPB BAC(-)_2, 
which maintained MIC for BAC, under BAC-exposed conditions (Table B 7 and Table B 
8). Further, no differentially expressed genes were found between the replicate 
populations, e.g., three replicates of BAC(+)_1 population, under the same conditions 
(i.e., BAC-free or BAC-amended), indicating that the differences identified by our RNA-
seq analysis above reflected largely biologically relevant adaptations and not merely 
higher noise of RNA versus DNA datasets and protocols. Therefore, our subsequent 
analysis was focused on these 303 genes differentially expressed in P. aeruginosa DPB 




Figure 3-2. Overexpression of efflux pump genes present in the ICE when 
BAC is supplemented in the growth media. Green bars represent 
comparisons between P.aeruginosa DPB ancestor in LB growth media 
versus LB+BAC media (AL_vs_AB); yellow show comparisons between 
P. aeruginosa DPB_Control_2 in LB vs. LB+BAC (C2L_vs_C2B). AL: 
P.aeruginosa DPB ancestor in LB growth media; AB: P.aeruginosa DPB 
ancestor in LB+BAC media; C2L: P. aeruginosa DPB_Control_2 in LB 
media; C2B: P. aeruginosa DPB_Control_2 in LB+BAC media. 
3.4.4 Restricted growth as an adaptation to high BAC concentrations 
 With a sub-inhibitory concentration of BAC in the growth medium, expression of 
phosphorus utilization related genes significantly decreased in the evolved DPB BAC(+) 
populations compared to the ancestor (Figure 3-3A and Table B 5). It is unlikely that 
these expression patterns were attributable to the lower phosphorus concentration or 
different phosphorus species in the LB medium because the control population, which 
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was propagated on LB, did not show similar gene expression patterns (note also that 
expression differences in control vs. ancestor were removed from further analysis in 
order to avoid such effects of LB growth medium, as noted above). Significantly 
decreased expression (-2.24 log2 fold change, on average, padj < 0.01) of the phosphate-
specific transport (pst) operon (pstSCAB and phoU) and the phoB gene, encoding a 
transcription activator of the two component regulatory system phoBR, was observed in 
all P. aeruginosa DPB BAC(+) populations. P. aeruginosa possesses a pst system (high 
affinity phosphate transport) which is activated by phosphate limitation (170) leading to 
phosphate taxis, and deletion of the pstCAB and phoU genes results in restrain of 
phosphate taxis even in conditions of phosphate excess (171). Therefore, decreased 
expression of pst operon suggested lower uptake of phosphate. Furthermore, significantly 
decreased expression of phosphonate utilization pathway (-2.69 log2 fold change, on 
average, padj < 0.01) was observed in all P. aeruginosa DPB BAC(+) populations, 
especially the ATP-binding protein of the phosphonate ABC transport system phnC, 
ABC transporter substrate-binding protein phnD, phosphonates transporter phnE, and 
carbon-phosphorus lyase complex subunit phnJ. Phosphonates are P compounds (valence 
+3) with a C-P bond instead of the more common C-O-P bond (valence +5 of P) found in 
phosphate esters, so the strength of C-P bond makes phosphonates resistant to chemical 
and enzymatic hydrolysis (172). Some microorganisms are known to be able to utilize 
phosphonates as a P source and phosphonates utilization pathways have been reported 
with detailed genetic and biochemical evidence (173, 174). Therefore, the lower 
expression of these genes was also consistent with decreased phosphorus utilization as an 
effect of exposure to high BAC concentrations.   
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 Adaptation to high concentrations of BAC resulted in additional significant 
changes, mostly a decrease in expression of genes related to various metabolic pathways 
such as fatty acid biosynthesis, the nitrogen cycle and energy metabolism in all P. 
aeurginosa DPB BAC(+) populations compared to the ancestor (Figure 3-3A). Firstly, 
decreased expression of acetyl-CoA carboxylase biotin carboxyl carrier protein subunit, 
acetyl-CoA carboxylase biotin carboxylase subunit, and 3-oxoacyl-ACP synthase III, 
which are involved in the fatty acid biosynthetic process (-2.17 log2 fold change, on 
average, padj < 0.01), and decreased expression of acyl-CoA dehydrogenase (-1.33 log2 
fold change, on average, padj < 0.01), which is the initial step of fatty acid beta-
oxidation, were observed. Secondly, the expressions of almost all genes related to energy 
metabolism (i.e., the electron transport system) were decreased. For instance, the 
expression of genes involved in an electron transfer chain such as those encoding the 
cbb3-type cytochrome c oxidase subunits (i.e., ccoN, ccoO, ccoQ, and ccoP), the 
cytochrome c biogenesis gene ccsA, and the cytochrome c4, 2-nonaprenyl-3-methyl-6-
methoxy-1,4-benzoquinol hydroxylase which is part of ubiquinone (cofactor) 
biosynthetic pathway, and ferredoxin decreased by 2.43 log2 fold change, on average 
(padj < 0.01), relative to the ancestor. Furthermore, significantly decreased expression of 
roxR (encoding a response regulator of RoxSR two-component regulatory system) and 
cyanide insensitive terminal oxidases (i.e., cioA and cioB) were observed in all P. 
aeruginosa DPB BAC(+) populations (-1.71 log2 fold change, on average, padj < 0.01). 
This result was consistent with previous findings that RoxR is a direct positive 
transcriptional regulator of a cyanide-insensitive oxidase that is part of the electron 
transport system in P. aeuriginosa (175). Finally, we observed significantly reduced 
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expression of ribonucleoside-diphosphate reductase (-1.78 log2 fold change, on average, 
padj < 0.01), which is responsible for the production of the precursors necessary for DNA 
synthesis. Altogether, reduced expression of genes related to cell energy metabolism, 
various metabolic pathways, and decreased uptake and utilization of phosphorus 
suggested that evolved P. aeruginosa DPB BAC(+) populations adapted to high 
concentrations of BAC might alter their growth characteristics (e.g., lag time or growth 
rate).  
 Reduction of the growth rate is known to be beneficial for bacterial populations 
exposed to antibiotics such as beta-lactams, which are cell-envelope disrupting agents 
like BACs, and other stress exposed conditions (176, 177). Therefore, slow growth rate 
might be beneficial for the high concentration of BAC adaptation. Consistent with these 
interpretations, we noted a slower growth rate in all DPB BAC(+) populations growing in 
1000mg/L BAC relative to that of the ancestor grown in the presence of 100mg/L BAC 
(P < 0.01, Student’s t-test) (Table 3-1). Furthermore, the average total cell count of the 
ancestor during the stationary phase under BAC-exposed conditions (100mg/L BAC) was 
3.87*10^7 CFU/mL, which was 2.5 fold higher than that (1.52*10^7 CFU/mL) of P. 
aeruginosa DPB BAC(+) populations under BAC-exposed conditions (1000mg/L BAC) 




Figure 3-3. Gene expression changes in BAC-adapted P. aeruginosa DPB 
populations. Average log2 fold change values of three replicate for each 
population and ancestor were used. (A) Decreased expression of genes 
related to growth in P. aeruginosa DPB BAC(+) populations versus their 
ancestor in LB+BAC media (AB_vs_BAC(+)). (B) Overexpression of 
spermidine synthesis genes and pmrAB, and decreased expression of Mg2+ 
transport ATPase. (C) Overexpression of muxABC-opmB RND efflux 
pump and decreased expression of oprG porin, for the same comparison. 
AB: P.aeruginosa DPB ancestor in LB+BAC media; BAC(+)_1B: P. 
aeruginosa DPB BAC(+)_1 population in LB+BAC media; BAC(+)_2B: 
P. aeruginosa DPB BAC(+)_1 population in LB+BAC media; 





Table 3-1. Growth characteristic parameters in P. aeruginosa DPB 
ancestor and BAC(+) populations at sub-inhibitory concentrations of 
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BAC. See Experimental procedures for details on how cells were grown 
and growth rate was measured. 








Maximal growth rate 
(OD 600nm/hour) 
0.15 ± 0.01 0.11 ± 0.004 0.06 ± 0.01 0.13 ± 0.04 
Lag time (hours) 4.36 ± 0.44 6.69 ± 0.24 2.67 ± 0.37 6.4 ± 0.33 
 
3.4.5 Stress-related genes 
 We also examined additional genes that were suspected to be involved in BAC-
resistance based on the (known) mode of action of BAC. Exposure to sub-lethal 
concentrations of cetyltrimethylammonium bromide, another member of QAC family, 
induces oxidative stress by generating reactive oxygen species (ROS, e.g., superoxide 
and hydrogen peroxide) in E. coli cells (178). Accordingly, bacteria subjected to BAC are 
known to induce genes for ROS-scavenging antioxidants such as catalase and alkyl 
hydroperoxide reductase (179, 180). The expression of the gene encoding universal stress 
protein A (UspA) is also elevated in response to various kinds of stress conditions 
including oxidant exposure and in the presence of polymyxin or other antibiotics (181). 
However, when P. aeruginosa DPB BAC(+) populations were exposed to sub-inhibitory 
concentrations of BAC, the expression of alkyl hydroperoxide reductase, catalase, and 
uspA decreased by 1.49 of average log2 fold (padj < 0.01) relative to the ancestor (Table 
B 5), indicating that expression of these stress-related genes does not represent a major 
physiological adaptation to BAC exposure, at least in the P. aeruginosa strains. On the 
other hand, we observed elevated expression of stress-induced gene ygiW (+2.64 log2 fold 
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change, on average, padj < 0.01) in all P. aeruginosa DPB BAC(+) populations (Table B 
5). The E. coli ygiW mutant is sensitive to hydrogen peroxide and produces elevated 
levels of biofilm with the expression of flagellar biosynthesis genes (182); ygiW is also 
known to be induced by hydrogen peroxide (183). Although the mechanisms by which 
ygiW protects cells from hydrogen peroxide remain unknown, the increased expression of 
ygiW in all P. aeruginosa DPB BAC(+) populations is consistent with the previous 
studies that QAC induce oxidative stress by generating ROS (178). Overall, these results 
indicate that protection from the oxidative stress induced by exposure to a sub-inhibitory 
concentration of BAC might not be the primary BAC resistance mechanism that allows 
P. aeruginosa DPB BAC(+) populations to withstand high concentrations of BAC 
compared to their non-adapted ancestor. 
3.4.6 Spermidine 
 Extracellular DNA can function as a nutrient source, a biofilm component and as 
a cation chelator, which can result in growth inhibition and thus, has implications for 
antibiotic resistance (184). Because DNA can sequester divalent metal cations, exposure 
to high levels of extracellular DNA induces the Mg2+-responsive PhoPQ and PmrAB 
two-component systems, which control many genes required for virulence and 
antimicrobial peptide resistance (184). Exposure to sub-lethal concentrations of 
extracellular DNA and membrane-targeting antibiotics induces expression of genes 
PA4773 to 4775 of the P. aeruginosa type strain, which are putatively annotated as 
spermidine and other polyamine synthesis genes. Polyamines are produced under Mg2+-
limiting conditions and can act as an organic polycation to bind lipopolysaccharide 
(LPS). Thus, these polyamines can stabilize and protect the outer membrane against 
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antibiotic (i.e., polymyxin B) and oxidative damage (i.e., hydrogen peroxide) (185). 
Interestingly, both expression of spermidine synthase gene operon, which is almost 
identical to genes PA4773 to 4775, and expression of pmrAB operon genes, which are 
located downstream of the spermidine synthase operon (i.e., PA4776 and PA4777), were 
significantly increased by a 2.39 and a 2.27 log2 fold change, on average (padj < 0.01), 
respectively, in all P. aeruginosa DPB BAC(+) compared to the ancestor (Figure 3-3B 
and Table B 5). Furthermore, significantly decreased expression of Mg2+ transport 
ATPase (mgtA) was also observed (-3.71 log2 fold change, on average, padj < 0.01) 
(Figure 3-3B and Table B 5). Therefore, these results indicate that a chloride ion in BAC 
might act as a cation (e.g., Mg2+) chelator, destabilizing the cellular membrane, and P. 
aeruginosa DPB BAC(+) populations evolved to express more spermidine synthase 
genes when exposed to BAC conditions in order to protect cells from either membrane 
damaging BAC and/or oxidative stress possibly induced by BAC exposure. 
3.4.7 Efflux pumps and porins 
 In addition to the ICE-encoded efflux pumps genes mentioned above, we also 
examined the chromosomal encoded ones. MuxABC-OpmB is an RND-type multidrug 
efflux pump that has been reported to confer resistance to novobiocin, aztreonam, 
macrolides, and tetracycline (186), and inactivation of the MuxABC-OpmB transporter 
leads to ampicillin and carbenicillin susceptibility (187). Moreover, the muxABC-opmB 
genes expressed by metabolically active subpopulation in P. aeruginosa biofilm when 
exposed to colistin (polymyxin E) was necessary for colistin resistance but did not affect 
resistance to the chelator EDTA, the detergent SDS, or chlorhexidine (188). A modest 
increased expression of the muxABC-opmB genes (+1.21 log2 fold change, on average, 
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padj < 0.01) (Figure 3-3C and Table B 5) indicated that BAC may also be a substrate for 
this efflux pump. However, the latter finding awaits experimental verification because 
none of the previous studies of the muxABC-opmB genes was focused on BAC. OprG is 
one of the major outer membrane proteins (e.g., OprD, OprE, OprF, and OprH) in P. 
aeruginosa (189). The function of OprG has not been clearly elucidated and several 
studies reported that decreased expression of oprG was related to increased resistance to 
antibiotics such as tetracycline and kanamycin (190). However, other studies reported 
that expression of oprG under iron-rich anaerobic conditions was increased but OprG was 
not involved in iron or antibiotic uptake (191) and interestingly OprG might mediate the 
diffusion of small hydrophobic molecules across the outer membrane based on structural 
analysis (192). Because the first step of mode of action for BAC is adsorption and 
penetration of the BAC into the cell wall and BAC has a long hydrophobic alkyl chain, 
which can be a substrate for OprG, decreased expression of the oprG gene by a 1.89 log2 
fold change, on average (padj < 0.01) in all P. aeruginosa DPB BAC(+) populations 
compared to the ancestor at sub-inhibitory concentration of BAC might be beneficial to 
prevent BAC from entering into the cells (Figure 3-3C and Table B 5). However, further 
experimental tests are necessary to test these hypotheses in order to clarify the 
mechanisms of BAC resistance.   
3.5 Conclusions and outlook 
 It should be noted that BAC are often combined with other chemicals (e.g., 
excipients) in typical disinfectant formulations, which could increase BAC potency 
(193); no excipients were used in our study.  Nonetheless, experimental adaptation to 
increasing concentrations of BAC rendered P. aeruginosa resistant to high BAC 
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concentrations, ranging from 480 mg/L BAC to 1600 mg/L BAC, which are comparable 
to, or even higher, than those used in practice for disinfection, e.g., typically between 
400-500 mg/L (146). Given the high stability of BAC in the environment and several 
outbreaks linked to contaminated QAC-based antiseptic solutions, these results 
underscored the need for further investigation of the mechanisms of BAC resistance.  
 Our genomic and transcriptomic analysis on BAC-evolved P. aeruginosa 
suggested that BAC resistance was both at the level of cell physiology (e.g., gene 
regulation) and genomic adaptations (e.g., fixed mutations). After 3 years of exposure to 
a sub-inhibitory concentration of BAC within the DPB bioreactor, P. aeruginosa 
acquired an ICE encoding several efflux pump proteins that were likely responsible for 
BAC resistance based on bioinformatics gene function annotation. In the present study, 
we showed that these genes were also overexpressed under BAC-exposed conditions 
compared to BAC-free conditions (e.g., Figure 3-2), further corroborating the 
bioinformatics predictions that the genes are related to BAC resistance. Moreover, the 
physiological adaptations to high BAC concentrations appeared to include a combination 
of reduction of phosphorus utilization/uptake and energy production (e.g., electron 
transfer chains), slower growth in general, and altered expression of efflux pump genes 
and porins. These extensive and multi-facet differences at the transcriptome level 
contrasted with those at the DNA level, which revealed only a single gene in common 
that had undergone mutations during BAC exposure (pmrB). Specifically, after 
experimental adaptation to high concentrations of BAC, fixed mutations in pmrB allowed 
P. aeruginosa to be resistant to BAC via expression of genes related to stabilization of 
cell surface charge (e.g., 4-amino-L-arabinose and spermidine synthesis). Therefore, 
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several independent mechanisms were employed by evolved P. aeruginosa populations 
to tolerate ~7 fold higher BAC concentration relative to its ancestral population.  
 Our results revealed that reduction of growth and stabilization of cell surface 
charge represented two of the major BAC resistance mechanisms. This finding suggested 
that highly-sensitive, culture-independent detection methods such as qPCR could be used 
to monitor the microbial contamination of disinfectant manufacturing facilities or hospital 
disinfectant stocks in order to prevent outbreaks associated with contaminated stocks or 
storage (35, 157). In particular, mutations in pmrB can be used as potential biomarkers to 
detect BAC-resistant organisms, especially P. aeruginosa. Furthermore, because our 
results suggested that stabilizing cell surface charge by the production of cationic 
polyamines represents another major BAC resistance mechanism, adjusting (e.g., 
lowering) the pH of the water in the antiseptic processing lines could be helpful in 
removing any remaining BAC-resistance pathogens. However, adjusting the pH might 
not be always easy or even possible. Finally, BAC evolved P. aeruginosa showed 
changes in the expression of several virulence factors (e.g., Type III secretion systems 
and genes related to motility) under both BAC-free and BAC-exposed conditions (Table 
B 3, Table B 4, Table B 5, and Table B 6). These results implied that exposure (and 
resistance) to BAC of pathogens may also alter their virulence, e.g., decreased expression 
of Type III secretion systems and motility genes in BAC adapted populations, or 
increased expression of pyoverdine biosynthesis genes (Table B 3, Table B 4, Table B 5, 
and Table B 6), which warrants further investigation.  
It is important to note that our experimental design (e.g., semi-continuously fed, 
mixed batch culture) represents a good model for engineered biological wastewater 
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treatment systems used in poultry meat, pharmaceutical processing facilities). For 
instance, BAC often accumulate in such facilities due to the continuous input and 
adsorption to biomass (194) and thus, our experimental design based on increasing BAC 
concentrations (Figure 3-1B) simulate this scenario well. Further, our results showed that 
the triplicate BAC adapted P. aeruginosa DPB populations were able to maintain their 
high MIC even after BAC was removed from the feed for at least one hundred 
generations. Hence, our findings are -in general- realistic with respect to practice. 
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4.1 Abstract 
 Improper or lack of sanitary conditions can enhance the infection of enteric 
pathogens, resulting in illness and even death of children in low-income countries. By 
employing metagenomic analysis of stool samples, we examined associations between 
several environmental variables, including sanitation interventions, and gut microbiome 
composition in 122 children under 48 months old in a low-income, urban neighborhood 
setting in Maputo, Mozambique. While age was the most influential variable on 
microbial community composition differences among the children sampled, antibiotic 
resistance gene (ARG) and virulence factor (VF) abundances as well as other variables 
including sanitation intervention, diarrhea status, compound sanitary index, and 
compound level population density also contributed significantly to the differences 
observed (P value of < 0.05, PERMANOVA). Especially, Veillonella parvula, an 
opportunistic pathogen, was higher in the control group (no sanitation) and diarrhea 
group compared to the sanitation intervention and the non-diarrhea (no disease 
symptoms) groups. We were able to recover several genomes representing known as well 
as novel taxa that were differently abundant between the sanitation intervention group 
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and the control group and thus, should be subjects of future research. Collectively, these 
results suggested that sanitation interventions might induce small but significant 
differences in abundance of at least several microbial species, including V. parvula, and 
expanded the genomic diversity of species present in the children microbiome. However, 
pathogen load in the metagenomes analyzed remain high in children with intervention 
compared to their matched controls, indicating alternative routes of infection that remain 
uncontrollable. 
4.2 Introduction 
 Diarrhea causes 1.7 million annual deaths, mostly to children living in low-
income countries where basic sanitation conditions do not exist (43, 48, 195). Several 
distinct species of bacteria, viruses, and protozoa have been identified as the leading 
causative agents of diarrhea (85, 196). However, the impact of enteric infections is likely 
underestimated because of the presence of asymptomatic individuals (85, 196, 197). 
These symptomatic and asymptomatic infections have major effects on (lower) cognitive 
and physical growth in early childhood, leading often to death, and have been generally 
reported to be associated with poor water, sanitation and hygiene (WASH) conditions 
(198, 199). 
 Several recent studies have reported no significant associations between improved 
WASH conditions, especially sanitation interventions, and enteric infections or health 
conditions such as the incidence of diarrhea (81-84). However, the effects of WASH 
conditions on enteric infections can be complex and not easy to quantify due, for 
instance, to lack of precision in WASH outcome measures, including self-reported (as 
opposed to objectively measured) diarrhea and comparison of data from various settings 
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such as rural vs. urban areas (75, 80, 200, 201). Self-reported diarrhea does not account 
for asymptomatic infection either (202-204). Furthermore, the majority of studies 
regarding sanitation have focused on rural regions while only a few studies have 
attempted to understand the effect of sanitation on human health in rapidly growing urban 
areas (48, 75, 205). Densely populated urban areas without proper sanitary infrastructure 
can facilitate fecal contamination and enteric pathogen transmission within the 
community, which can increase the risk of exposure to pathogens and thus, render 
sanitation interventions ineffective (47, 48). Therefore, there is a need to investigate the 
association between sanitation and human health in urban areas that lack adequate 
sanitation facilities.  
 Furthermore, many studies in the WASH research field have employed a 
standardized microbiology protocol from the Etiology, Risk Factors, and Interactions of 
Enteric Infections and Malnutrition and the Consequences for Child Health and 
Development Project  (MAL-ED) for sample collection and analysis (85, 86). 
Specifically, this protocol employs culture, microscopy, immunoassay, and PCR for the 
detection of a specific list of pathogens. In addition to this, a number of other recent 
WASH studies used multiplex PCR assay to determine the presence or absence of 
representative pathogens (48, 87, 88). These conventional procedures for the detection 
and identification of various pathogens are time-consuming and labor intensive, and the 
PCR based approaches can even produce false-positive signal due to primer hybridization 
with non-target DNA/RNA (206). Further, the primers used in the PCR assays are 
designed based on available genomes and thus, cannot capture novel or divergent at the 
sequence level pathogens. Contrasting with these conventional methods, metagenomic 
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sequencing represents a more unbiased approach that can theoretically detect and 
genotype all pathogens present in a sample and can uncover unknown pathogens or 
commensals (207). Preliminary analysis of a small sample size has shown that the gut 
microbiomes of non-westernized populations, including Africans, show profound 
differences compared to those of westernized populations (208, 209). Thus, it is 
important to apply metagenomic approaches to examine the association between 
sanitation and gut microbiome, including but not limited to the presence or absence and 
relative abundance of enteric pathogens in the gut microbiomes of African children, 
which are currently underrepresented in the public databases.               
 In the context of Maputo Sanitation (MapSan) trial in urban neighborhoods of 
Maputo, Mozambique (64), which employed pour-flush latrines (to septic tank) sanitation 
intervention shared by multiple households, we investigated the effect of various 
variables, including sanitation conditions, on the gut microbiome of children under 48 
months old in a low-income. 
4.3 Materials and Methods 
4.3.1 The Maputo Sanitation (MapSan) study design 
 The MapSan project, a controlled before-and-after study of the impact of an urban 
sanitation intervention on children health in Maputo, Mozambique, was conducted 
between February 2015 and September 2018 (64). The sanitation intervention, built by 
the non-profit implementation agency Water and Sanitation for the Urban Poor, involved 
shared private latrines used by a minimum of two households, with pour-flush toilets to 
septic tanks (non-sewerage). The number of latrine cabins depends on the number of 
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beneficiaries in the compound (grouping of houses sharing sanitation and outdoor living 
space). Compounds with ≤20 people were provided a single cabin “Shared Latrine,” and 
compounds with >20 people received a “Communal Sanitation Block” (CSB) with one 
latrine cabin per 20 people residing in the compound. The CSB interventions also 
included facilities such as laundry and washing units, rainwater and municipal water 
storage, and handwashing stations. Control sites, which did not receive upgraded 
sanitation, were enrolled concurrently with intervention sites. Selection criteria for 
intervention and control sites have been described in detail elsewhere (1, 2). Briefly, all 
study sites must have had (i) shared sanitation in poor condition (e.g., pit latrines or pit 
latrines with slabs or non-function pour flush latrines), (ii) a piped water supply nearby, 
(iii) a minimum number of beneficiaries, (iv) stated demand for improved sanitation, and 
(v) an eligible child. When possible, control sites were selected to have a similar number 
of residents as concurrently enrolled intervention sites.  The criteria for enrollment of 
children were (i) age range between 1 and 48 months at the time of enrollment, (ii) 
available written informed consent by child’s guardian, and (iii) met site criteria 
described above. The study protocol was approved by the Comite´ Nacional de Bioe´tica 
para a Sau´de (CNBS), Ministe´rio da Sau´de (333/CNBS/14), the Ethics Committee of 
the London School of Tropical Medicine and Hygiene (reference # 8345), and the 
Institutional Review Board of the Georgia Institute of Technology (protocol # H15160). 
The associated MapSan trial has been registered at ClinicalTrials.gov (NCT02362932).  
 In total, we sequenced 122 stool samples from children in three age groups, i.e., 
1-11 months, 12-23 months and 24-48 months. The samples were categorized into four 
different groups: baseline control, baseline intervention, midline control and midline 
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intervention (Table 4-1A). The first group of samples selected for metagenome 
sequencing in Spring 2017 were all aged 7-14 months old. To select these samples, the 
following procedure was used. First, we identified as many samples as possible from the 
midline phase that were between 8 and 12 months old, had stool available in enough 
volume for metagenomics, and were under sanitation intervention. These were matched 
to samples from children with no intervention. Matching criteria were age (+/- 1 month) 
and sex. In total, we ended up with 26 intervention (13 from baseline, meaning first 
sample taken before sanitation is applied, and 13 from midline phase, after sanitation is 
applied) and 16 control (8 from baseline from controls that no sanitation was applied, and 
8 from midline phase) for a total of 42 samples. For the second group of samples selected 
for sequencing in December 2017, we chose samples from two different groups of 
children: (i) 40 additional samples from children 7-14 months at midline phase, equally 
split between intervention and control, and (ii) 40 samples from children aged 2-3 years 
(i.e., older children, being under intervention for 12 month) at midline phase, equally split 
between intervention and control. Most of sub-group (i) were also subjected previously to 
AMR qPCR (35/40) for comparison to the qPCR array results. The other 5 for this age 
sub-group were chosen randomly after imposing certain practical criteria, i.e., making 
sure that equal numbers of intervention and control samples were used (20 each), and that 
there was enough stool material available for analysis. 12 of the sub-group (ii) samples 
(2-3 year old; out of 40, in total) were chosen because we had included the matched 
baseline sample in the first group of  samples described above (1st paragraph) and these 
represent samples from children under sanitation that can be compared to the samples 
from the same children before sanitation. The remaining 28 were randomly selected after 
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taking into consideration samples with enough stool material for the analysis and 
achievement of balance of intervention vs control (20 of each). 
 We defined diarrhea as ≥ 3 loose or liquid stools in a 24-hour period or any stools 
with blood (210). Metadata used in this study are presented in Table 4-1B. Breastfeeding 
was present in all 1-11 months old samples. Thus, breastfeeding was not independent of 
age, and we did not consider breastfeeding as an independent variable.   
4.3.2 DNA extraction and sequencing 
 Approximately 0.1 g of each fecal sample was taken for total DNA extraction and 
processed with the standard Manual of Procedures (MoP) suggested by the Human 
Microbiome Project (HMP- http://hmpdacc.org/resources/tools_protocols.php). DNA 
quantification was achieved using Quibit dsDNA HS Assay Kit (Thermo Fisher 
Scientific). DNA libraries were prepared using the Nextera XT DNA library prep kit 
(Illumina, San Diego, CA) and were sequenced using an Illumina HiSeq 2500 instrument 
(Georgia Institute of Technology). 
4.3.3 Bioinformatics data analysis 
 Metagenomic reads were quality-trimmed with SolexaQA, using phred quality 
cut-off of 20. Reads shorter than 50 bps after trimming were discarded (108). Trimmed 
reads were then filtered by BMTagger to identify human reads (211). Non-human reads 
were then used for the rest of the analyses to investigate the gut microbiome. The 
estimated abundance-weighted average coverage of each metagenomic dataset was 
calculated by Nonpareil version 3.20 with default parameters (212). Mash, a tool that 
uses the MinHash dimensionality reduction method to compare sample-to-sample kmer 
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composition (i.e., β-diversity) (213), was used to calculate pairwise mutation distance 
between whole metagenomic datasets with a kmer=25 option. Microbial community 
taxonomic composition was assessed based on clade-specific marker genes using 
MetaPhlAn2 v2.0 (214). To assess the abundance of antibiotic resistance genes (ARGs), 
deepARG (215), which identifies ARG-encoding metagenomic reads after searching 
them against an ARG database was used. Blastn search of metagenomic sequencing data 
against virulence factor database (VFDB) (216) with the cutoff of bitscore 60 was used to 
calculate the abundance of virulence factors (VFs) in the metagenomic datasets. Both 
ARG and VF abundances in metagenomes were normalized for metagenomic dataset size 
and average genome size of the microbial community samples using the frequency of 
reads encoding the single-copy rpoB gene. rpoB-encoding reads were identified by a 
ROCker model, as previously described (217), and the normalized values were presented 
as genome equivalents (GEs), i.e., fraction of total genomes sampled that encoded the 
gene of interest (assuming a single-copy for each gene per genome). 
 For metagenome assembly, paired-end reads were first merged using PEAR (218) 
(options: -p 0.001) and both merged and unmerged reads were quality-trimmed and 
human-filtered as described before. These processed merged and unmerged reads from 
single metagenomes (no co-assembly) were combined for assembly using IDBA-UD 
(219) (default options). Resulting contigs were binned into metagenome-assembled 
genomes (MAGs) using MaxBin and their completeness and contamination were 
assessed with CheckM (220, 221). Quality of MAGs was calculated as “Quality = 
Completeness – 5 × Contamination”, and MAGs with a quality score above 50 were used 
for further analysis. The Microbial Genome Atlas (MiGA) webserver was used to 
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determine the most likely taxonomic classification and novelty rank of good-quality 
MAGs against the classified species in NCBI’s prokaryotic genome database (222). To 
de-replicate the collection of MAGs, we applied a genome-aggregate average nucleotide 
identity (or ANI) cutoff of 95%, and selected one MAG with the highest quality score as 
the representative of each resulting 95% ANI-based genomospecies. For the strain level 
de-replication of MAGs within a genomospecies, a ANI 99% cutoff was used. The 
relative abundance of MAGs and their encoded ARG in all metagenomes was calculated 
by competitive bowtie2 alignment (112) and normalized as GEs using ROCker model for 
rpoB as described above. Additionally, for a more conservative estimate, we calculated 
the 80% truncated coverage for MAG abundance using the BedGraph.tad.rb script of the 
Enveomics collection (115) to remove outliers genes in terms of coverage such as the 
rRNA and other multi-copy genes.  
4.3.4 Statistical Analyses 
 β-diversity (i.e., between samples taxa sharing), calculated from Mash distances, 
was visualized in a non-metric multidimensional scaling (NMDS) plot using the vegan 
package in R v3.5.1 (223). Permutational multivariate analysis of variance 
(PERMANOVA) was further used to reveal the effects of measured variables on the 
Mash distances (adonis function of the vegan package) (223). All differently enriched 
taxonomic and functional counts between different groups of samples, categorized by 
each variable, were identified by the Kruskal-Wallis test followed by Dunn’s post-hoc 
test with p-value adjustment with the Benjamini-Hochberg method using the FSA 
packages (224) in R v3.5.1. 
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4.3.5 Phylogenetic analysis of MAGs and reference genomes of Escherichia coli 
 Orthologous genes for E. coli MAGs and reference genomes were identified using 
reciprocal best matches (RBM) using the rbm.rb and ogs.mcl.rb scripts of the Enveomics 
collection (115, 225). The core orthologous genes (i.e., present in all genomes) were 
aligned using Clustal Omega (226) and a phylogenetic tree was built using the 
concatenated alignment with FastTree version 2.1.7 (227) and default options. The tree 
was visualized in iTOL (228). 
4.4 Results and discussion 
4.4.1 Characteristics of the samples and metagenomes 
 Out of the total 122 individual children sampled, 59 were 1-11 months old, 27 
were 12-23 months old and 36 were 24-48 months old at the time of sampling (Table 
4-1A). 21 baseline samples were excluded from any comparison that involved sanitation 
intervention as a variable because all these samples were collected prior to sanitation 
intervention. Among the remaining 101 samples, 56 samples were exposed to the 
sanitation intervention (i.e., a sanitation intervention group) while the remaining samples 
were not (i.e., a control group). We obtained between 5 to 22 million pair-ended reads 
after trimming per dataset (average read length of 115 to 136 bp per dataset). The 
estimated abundance-weighted average coverage calculated by Nonpareil for all 
metagenomes ranged between 81-97%, that is the fraction of the total community DNA 
that was sequenced, except for one sample that had 91% human contaminating reads. 
Even this metagenome, however, showed 70% coverage of the sampled microbial 
community, indicating high enough coverage for assembly and genome binning (Figure 
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4-1A). Except for this sample, 113/121 metagenomes contained less than 1% of human 
DNA, six metagenomes contained less than 5% of human DNA, and one contained 25% 
of human DNA. Assembly and binning effort produced a total of 963 high-quality quality 
(completeness – 5*contamination ≥ 50) metagenome-assembled genomes (MAGs), 
representing 153 95%-ANI-based genomospecies (Table C 1). Taxonomic classification 
through MiGA (222) suggested that 60 genomospecies showed less than 60% of genome-
aggregate average amino acid identity (AAI) of the shared genes with any known 
reference genome, indicating these MAGs represented at least novel genera, if not higher 
taxonomic ranks (Table C 1). This result corroborates the findings of recent studies that 
reported distinct gut microbiota in African human populations compared to European 
populations (208, 229, 230). 
Table 4-1. Samples used in this study by group. (A) 59 of the samples 
were from 1-11 months old children, 27 from 12-23 months and 36 from 
24-48 months. 
 Time Group Treatment # of samples 
Set 1 Baseline Control (C) 
Non-intervention 
(N) 10 
Set 2 Baseline Intervention (I) 
Non-intervention 
(N) 11 
Set 3 Midline Control (C) 
Non-intervention 
(N) 50 
Set 4 Midline Intervention (I) Intervention (S) 51 
 





Age A.1-11months, B.12-23months, C.24-48months 
Sanitation intervention Intervention or Control 
Gender 0: male, 1: female 
Compound sanitary 
score 
range 0-3 with higher numbers representing riskier conditions 
(Flooding, leaking wastewater, feces visible around compound 
grounds). 
Measure of  household 
level crowding binary as 0 for <=3 or 1 for >3 
Measure of compound 
level population density range 1-5 (higher numbers represent more dense) 
Chronic pain 0=no, 1=yes 




Figure 4-1. Microbial community diversity patterns. (A) Nonpareil curves 
of the samples used in the study (n=122). The circles of the curves 
represent the estimated average coverage at the sequencing depth/effort 
applied. Projected line to the right of the circle represents the expected 
coverage for higher sequencing efforts. Dashed lines represent the 95% 
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and 99% coverage levels. Curves positioned more on the right represent 
more sequence-diverse metagenomes compared to curves positioned on 
the left. 
4.4.2 Microbial community composition 
 Nonpareil curves (Figure 4-1A), a measure of combined species richness and 
evenness (total diversity), suggested that microbial communities of the sanitation 
intervention group show similar diversity to those of the control group (Nd values of 
16.88 ± 0.62 vs. 16.81 ± 0.60, respectively; P value of > 0.01, Student’s t-test). However, 
the microbial communities of the 24-48 months group were more diverse than those of 
the 1-11 months old group (Nd 17.18 ± 0.55 vs. 16.67 ± 0.57, respectively; P value of < 
0.001, Student’s t-test; note that Nd values are log scale, so a difference of 1 unit 
translates to 10-fold difference; see also Figure 4-1A). Similarly, Mash, a tool that uses 
kmer composition for β-diversity calculations, also revealed a clear separation of 24-48 
months microbial communities from those of the 1-11 months group. These results are 
consistent with those of previous studies that reported adult-like microbial composition 
for children of 3-4 year old but not the communities of younger children (53, 57, 58). No 
clear difference was observed between the sanitation intervention and the control groups 
in terms of Nonpareil Nd diversity values (Figure 4-1B). Permutational multivariate 
analysis of variance (PERMANOVA), a non-parametric test to evaluate the effects of 
variables through partitioning of variance, was performed in order to investigate the 
effect of age, sanitation intervention, gender, compound level sanitary conditions, 
compound level population density, household level crowding, chronic pain, and diarrhea 
on mash distance of the microbial communities. Interestingly, about 91% of the microbial 
community variation observed among samples was explained by the set of 8 variables 
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and their interactions (Table C 2). Specifically, age, diarrhea and a combination of 
compound sanitary index and diarrhea were significant in explaining diversity patterns (P 
value of < 0.05, PERMANOVA). Sanitation interventions together with age, compound 
sanitary index or compound level population density also explained small parts of the 
variation but not significantly (P value of < 0.1, PERMANOVA). These results revealed 
that age had the largest effect on the microbial community composition patterns observed 
between children (R2 value of 0.315, PERMANOVA) and sanitation intervention also 
explained small but significant parts of the diversity, especially in combination with the 
other variables such as age (R2 value of 0.055, PERMANOVA).  
 Because the microbial communities of the 1-11 months group showed a clear 
separation with those of the 24-48 months group, PERMANOVA was also performed for 
each age group separately in order exclude the effect of age on the Mash distances among 
the microbial communities. Similar to the results of all age groups reported above, the 
sanitation intervention on its own explained small parts of the variation but not 
significantly (P value of < 0.1, PERMANOVA) (Table C 3 and Table C 4), and it 
explained much larger fraction of diversity in combination with other variables. 
Interestingly, in the 24-48 months group, other environmental variables such as 
compound level sanitary conditions, compound level population density, and household 
level crowding, were significant in explaning variation (P value of < 0.05, 
PERMANOVA) (Table C 4). These observations suggested that sanitary conditions and 
population density have significant effects on the microbial community composition 
patterns especially in the older children who have been under sanitation for longer 
periods of time and/or are mobile.                
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4.4.3 Prevalence of virulence factors (VFs) and antibiotic resistance genes (ARGs) 
 Only the age variable showed significant effect on VF abundance while the 
effects of the seven other variables evaluated were not significant (Figure 4-2A) (P value 
of < 0.05, Kruskal-Wallis test). Specifically, both the 1-11 months (total VFs abundance, 
on median, 0.31; interquartile range [IQR], 0.14 to 0.78 genome equivalents or GEs) and 
the 12-23 months groups (total VFs, on median, 0.56; IQR, 0.24 to 1.48 GEs) showed 
significant higher VF abundance compared to that of the 24-48 months group (total VFs, 
on median, 0.03; IQR, 0.01 to 0.09 GEs) (adjusted P value [Padj] of < 0.05, Dunn’s post-
hoc test).  
 Consistent with the VF results, ARG abundance was significantly affected only 
by age among the eight variables tested (P value of < 0.05, Kruskal-Wallis test), and both 
the 1-11 months (total ARGs, on median, 4.14; IQR, 3.12 to 6.24 GEs) and the 12-23 
months groups (total ARGs, on median, 6.47; IQR, 3.57 to 13.05 GEs) showed 
significantly higher ARG abundance compared to that of the 24-48 months group (total 
ARGs, on median, 2.58; IQR 2.56 to 3.23 GEs) (Padj of < 0.05, Dunn’s post-hoc test) 
(Figure 4-2B). Various classes of ARGs were detected in all metagenomes, with 
multidrug, tetracycline, β-lactam and bacitracin showing the highest abundances in most 
of the metagenomes (Figure C 1). Because the Mozambican Ministry of Health has 
recommended the use of ampicillin and gentamicin (i.e., aminoglycoside class) for 
children under the age of 2, and chloramphenicol for older children (231), we further 
attempted to investigate the abundances of specific ARGs representative of these classes 
of antibiotics. Similar to the results mentioned above, only age affected the abundance of 
multidrug and aminoglycoside resistance genes (P value of < 0.05, Kruskal-Wallis test), 
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and higher abundances were observed in the 1-11 months (aminoglycoside and multidrug 
resistance gene abundance, on median, 0.16; IQR, 0.09 to 0.5 GEs and 1.24; IQR, 0.58 to 
2.33 GEs, respectively) and the 12-23 months group (aminoglycoside and multidrug 
resistance gene abundance, on median, 0.45; IQR, 0.17 to 1.04 GEs and 2.10; IQR, 0.84 
to 6.27 GEs, respectively) compared to the 24-48 months group (aminoglycoside and 
multidrug resistance gene abundance, on median, 0.03; IQR, 0.02 to 0.06 and 0.14; IQR 
0.06 to 0.56 GEs, respectively) (Padj of < 0.05, Dunn test) (Figure C 2A). This result is 
consistent with the (recommended) usage of gentamicin for children <2 year old. In case 
of β-lactam class, only the gender variable affected significantly the relative abundance 
of the corresponding ARGs (P value of  < 0.05, Kruskal-Wallis test), while the age was 
marginally significant (P value of ~ 0.078, Kruskal-Wallis test) (Figure C 2B). Sanitation 
intervention was the only variable that showed significance on the relative abundance of 
chloramphenicol resistance genes (P value of < 0.05, Kruskal-Wallis test). Specifically, 
the control group showed lower abundance of chloramphenicol resistance genes (median 
of 0.005; IQR, 0.002 to 0.013 GEs) compared to the sanitation intervention group 
(median of 0.012; IQR, 0.003 to 0.050 GEs) (Figure C 2C). Additionally, taxonomic 
affiliation of the bacterial genomes that encoded the ARG genes was also investigated. 74 
to 99% of the metagenomic reads encoding ARG were assignable to a set of MAGs 
representing 153 genomospecies (Figure C 3 and Table C 1). Only two genomospecies 
(i.e., ANIsp_33: best AAI match to Alistipes_finegoldii with 66.79% and ANIsp_46: best 
AAI match to Faecalibacterium_prausnitzii with 52.42%) showed significant difference 
between the control and sanitation intervention groups (P value of < 0.05, Kruskal-Wallis 
test); these genomospecies (and their encoded ARGs) showed slightly higher abundance 
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in the sanitation intervention (total ARG abundance, on median, 0; IQR, 0 to 0.004 and 0; 
IQR, 0 to 0.009 GEs in ANIsp_33 and ANIsp_46, respectively) vs. the control groups 
(total ARG abundance, on median, 0; IQR 0 to 0 and 0; IQR 0 to 0.0004 GEs in 
ANIsp_33 and ANIsp_46, respectively) (Figure C 4). Overall, these results suggested 
that sanitation intervention might not have a significant effect on the relative abundance 
of VFs or ARGs in the gut microbiome of Mozambican children. 
 
Figure 4-2. Relative abundance of VFs and ARGs in multiple age groups. 
(A) Total VFs abundance in three different age groups. (B) Total ARGs 
abundance in three different age groups. Abundance (y-axes) was defined 
as genome equivalents, i.e., what fraction of total cells/genomes sampled 
encoded the gene of interest, assuming that the genes are single-copy in 
the genome. The line that divides the box into 2 parts represents the 
median of the data. The end of the box shows the upper and lower 
quartiles. The extreme line shows the highest and lowest value, excluding 
outliers. 
4.4.4 Effect of sanitation intervention on species abundance 
 We examined species abundance differences between the sanitation intervention 
and the control groups to test the effect of the sanitation intervention on specific gut taxa 
and enteric pathogens using two distinct approaches, MetaPhlAn2 species profiles and 




























































unknown (not previously described) genomospecies. All good quality MAGs, 
representing 153 genomospecies, collectively recruited between 40 to 97% of the total 
reads, depending on the metagenome considered (Table C 1and Figure C 5). Out of 153 
genomospecies, seven genomospecies showed significant difference in abundance 
between the control and the sanitation intervention groups (P value of  < 0.05, Kruskal-
Wallis test) (Figure 4-3A). ANIsp_39 (closely related to Bacteroides_thetaiotaomicron 
with 98.13% AAI), ANIsp_46 (distantly related to Faecalibacterium_prausnitzii with 
52.42 % AAI), and ANIsp_84 (moderately related to Blautia_coccoides with 68.02% 
AAI) were more abundant in the sanitation intervention vs. the control groups (median 
coverage of 0.00001; IQR, 0 to 0.003 vs. 0; IQR, 0 to 0.00045, 0; IQR, 0 to 0.0001 vs. 0; 
IQR 0 to 0 ± 0.0004, and 0; IQR 0 to 0 vs. 0; IQR 0 to 0 GEs, respectively) (Figure 4-3). 
On the other hands, ANIsp_93 (distantly related to Paeniclostridium_sordellii with 
40.50% AAI), ANIsp_100 (distantly related to Ruminiclostridium_sp with 48.62% AAI), 
ANIsp_130 (closely related to Veillonella_parvula with 95.27% AAI), and ANIsp_143 
(distantly related to Streptococcus_parasanguinis with 46.08% AAI) were less abundant 
in the sanitation intervention vs. the control groups (median coverage of 0; IQR 0 to 
0.00015 vs. 0.0002; IQR, 0 to 0.0018, 0; IQR 0 to 0 vs. 0; IQR 0 to 0.000008, 0; IQR 0 to 
0  vs. 0; IQR, 0 to 0.0005, and 0; IQR 0 to 0  vs. 0; IQR, 0 to 0.00015 GEs, respectively) 
(Figure 4-3). 
 ANIsp_039, whose closest relative was B. thetaiotaomicron type strain VPI-5482 
with 98.13% of AAI, showed higher abundance in the sanitation intervention compared 
to the control group as mentioned the above. In addition to this, two other variables such 
as chronic pain and household level crowding also significantly affected that abundance 
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of B. thetaiotaomicron (P value of  < 0.05, Kruskal-Wallis test) (Figure 4-3B), while age, 
gender, compound level sanitary conditions and compound level population density were 
not strongly effecting the abundance of this species (P value of  > 0.05, Kruskal-Wallis 
test). More specifically, B. thetaiotaomicron showed higher abundance in the group 
having equal or less than 3 people in a household vs. the group having more than 3 
people in a household (median coverage of 0.000045; IQR, 0 to 0.002 vs. 0; IQR 0 to 0 
GEs, respectively), and also showed higher abundance in the presence of chronic pain vs. 
the absence of chronic pain groups (median coverage of 0; IQR, 0 to 0.0009 vs. 0.006; 
IQR 0.005 to 0.008 GEs, respectively) (Figure 4-3B). However, it should be noted that 
the number of samples in the chronic pain group is relatively low (n = 5). Hence, the 
results about chronic pain should be considered only as preliminary. B. thetaiotaomicron 
type strain VPI-5482 was originally isolated from the feces of a healthy adult human 
(232), and it has been reported to stimulate angiogenesis during postnatal intestine 
development resulting in increased capacity of the (human) host to absorb nutrients in 
germfree mice (233). Moreover, B. thetaiotaomicron regulates the synthesis of various 
gut epithelial glycans (234). However, this normally beneficial gut microbial species has 
also been shown to increase the virulence and disease progression of enteric pathogens 
such as enterohemorrhagic Escherichia coli (EHEC) by altering the metabolic landscape 
within the gut during murine infection, when the two species co-occur at a frequency of 
10:1 (235). Overall, it appeared that the combination of sanitation interventions and less 
household level crowding might have an effect to the (increased) abundance of B. 
thetaiotaomicron in the gut microbiota, which is generally beneficial to the host. 
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 V. parvula can be found in normal flora of the mouth, gastrointestinal tract, and 
vagina in humans but has also been implicated in various infections of the nose, lungs, 
heart, bone and central nervous system (236), and has also been isolated from bacterial 
vaginosis samples (237). Interestingly, V. parvula (ANIsp_130, Table C 1) showed 
higher abundance in the control vs. sanitation intervention groups (median coverage of 0; 
IQR, 0 to 0.0005 vs. 0; IQR, 0 to 0 GEs, respectively) and the diarrheal vs. the non-
diarrheal groups (median coverage of 0.0002; IQR, 0 to 0.001 vs. 0; IQR, 0 to 0.00003 
GEs, respectively) (Figure 4-3), while the other 6 assessed variables (age, gender, 
compound level sanitary conditions, compound level population density, household level 
crowding, and chronic pain) did not affect the abundance of V. parvula (P value of  > 0.1, 
Kruskal-Wallis test). Consistently, MetaPhlAn2 results showed that the abundance of V. 
parvula was not only higher in the control group compared to the sanitation intervention 
group (median percentage of relative abundance of 0.063; IQR, 0 to 0.18 vs. 0.012; IQR, 
0 to 0.05, respectively) but also was higher in the diarrhea group compared to the non-
diarrhea group (median percentage of relative abundance of 0.12; IQR, 0.04 to 0.59 vs. 
0.016; IQR, 0 to 0.07, respectively) (P value of  < 0.05, Kruskal-Wallis test) (Figure 4-4). 
These results indicated that V. parvula might be an indicator of a non-healthy or 
abnormal intestinal microbiota in Mozambican children that its abundance is significantly 
affected by the sanitation interventions. Furthermore, similar to V. parvula, two 
additional novel taxa, ANIsp_93 (distantly related to Paeniclostridium sordellii with 
40.50% AAI) and ANIsp_143 (distantly related to Streptococcus parasanguinis with 
46.08% AAI), were more abundant in the control and the diarrhea group than their 
counterparts (Figure 4-3). These observations suggested that these previous three taxa can 
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be the potential biomarkers for the effect of sanitation intervention on health condition. 
However, further experimental work is needed in order to corroborate these findings and 
elucidate the exact role of these taxa in the gut microbiome of Mozambican children. 
 MetaPhlAn2 analysis identified a total of 397 microbial species including 
pathogens such as Camplybacter jejuni, Shigella flexneri, Shigella sonnei, Salmonella 
enterica, Clostridium difficile and Human adenovirus, together with commensal taxa. Out 
of total 397 species, the relative abundance of 10 species (i.e., Anaerotruncus 
colihominis, Bifidobacterium angulatum, Clostridium symbiosum, Eubacterium limosum, 
Specifically, Lachnospiraceae bacterium, Lactobacillus pentosus, Mitsuokella multacida, 
Escherichia sp. (unclassified), Lactobacillus ruminis and Veillonella parvula) was 
different between the sanitation intervention group and the control group (P value of  < 
0.05, Kruskal-Wallis test). A. colihominis, C. symbiosum, Escherichia sp., E. limosum, 
and L. bacterium were more abundant in the sanitation intervention vs. the control groups 
(median percentage of relative abundance of 0; IQR 0 to 0 vs. 0; IQR 0 to 0, 0; IQR 0 to 
0.015 vs. 0; IQR 0 to 0, 0.46; IQR, 0.09 to 1.61 vs. 0.04; IQR, 0 to 0.84, 0; IQR, 0 to 0 
vs. 0; IQR, 0 to 0, and 0; IQR, 0 to 0 vs. 0; IQR, 0 to 0, respectively). On the other hands, 
B. angulatum, L. pentosus, L. ruminis, M. multacida, and V. parvula were less abundant 
in the sanitation intervention vs. the control groups (median percentage of relative 
abundance of 0; IQR, 0 to 0 vs. 0; IQR, 0 to 0, 0; IQR, 0 to 0 vs. 0; IQR, 0 to 0, 0; IQR, 0 
to 0 vs. 0; IQR, 0 to 0.91, 0; IQR, 0 to 0 vs. 0; IQR, 0 to 0, and 0.012; IQR, 0 to 0.05 vs. 
0.06; IQR, 0 to 0.18, respectively). 
 Especially, Escherichia sp., V. parvula and L. ruminis appeared to be highly 
enriched in both the sanitation intervention and the control groups, i.e., >0.1% of the total 
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metagenomes. L. ruminis, which was from the feces of humans and other animals (238, 
239) and is considered to be a member of the autochthonous gut microbiota with possible 
positive roles in host-microbe crosstalk (240-242), was less abundant in the sanitation 
intervention relative to the control group (Figure 4-4A). Notably, we were also able to 
recover MAGs related to the L. ruminis (ANIsp_44 with 96.57% AAI, Table C 1), but its 
abundance was not significant different between the control and the sanitation 
intervention groups, which was not consistent with the results of MetaPhlAn2 analysis. 
Thus, the relevance of L. ruminis as a biomarker of the effect of sanitation interventions 




Figure 4-3. Differently abundant species between the control and the 
sanitation intervention groups (MAG). Abundance (y-axes) was defined 
as genome equivalents, i.e., how many of the total cells/genomes samples 
represent a certain MAG ,assuming that the coverage of rpoB (a single 
copy gene) represents the size/coverage of whole microbial community. 
(A) Average relative abundance of 7 genomospecies that were 
differentially abundant between the control and sanitation intervention 
groups are shown, i.e., ANIsp_39 (closest relative to 
Bacteroides_thetaiotaomicron with 98.13% AAI), ANIsp_46 (closest 
relative to Faecalibacterium_prausnitzii with 52.42 % AAI), ANIsp_84 
(closest relative to Blautia_coccoides with 68.02% AAI), ANIsp_93 
(closest relative to Paeniclostridium_sordellii with 40.50% AAI), 
ANIsp_100 (closest relative to Ruminiclostridium_sp with 48.62% AAI), 
ANIsp_130 (closest relative to Veillonella_parvula with 95.27% AAI), and 
ANIsp_143 (closest relative to Streptococcus_parasanguinis with 46.08% 
AAI). Values above 0.008 were not shown here for clarity but included in 
all statistical tests. (B) Boxplots of the relative abundance of ANIsp_039 
(closest relative to Bacteroides_thetaiotaomicron with 98.13% AAI) in two 
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household level crowded groups and two diarrheal groups. (C) The 
abundance differences of ANIsp_093 (closest relative to 
Paeniclostridium_sordellii with 40.50% AAI), ANIsp_100 (closest relative 
to Ruminiclostridium_sp with 48.62% AAI), ANIsp_130 (closest relative 
to Veillonella_parvula with 95.27% AAI) and ANIsp_143 (closest relative 
to Streptococcus_parasanguinis with 46.08% AAI) between the diarrhea 
group and the non-diarrhea group are shown. 
 
Figure 4-4. Differently abundant species between the control and the 
sanitation intervention groups (MetaPhlAn2). (A) Boxplots of the relative 
abundance of Escherichia sp., Lactobacillus ruminis and Veillonella 
parvula in the control group and sanitation intervention groups are 
shown. (B) A boxplot of the relative abundance of V. parvula between the 
diarrhea group and non-diarrhea group (inset) is shown. 
4.4.5 Escherichia coli in the gut of Mozambican children 
 Typically, E. coli is an important member of the normal intestinal microflora of 
humans and other mammals and an early colonizer of infant intestines (243, 244), but it 
can also be a highly versatile or even deadly pathogen by acquiring specific virulence 
attributes (245). For example, The Global Enteric Multicenter Study (GEMS), which 
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identified the etiology and population-based burden of pediatric diarrheal disease in sub-
Saharan Africa and South Asia, reported that enterotoxigenic E. coli (ETEC) and typical 
enteropathogenic E. coli (EPEC) are associated with increased risk of death in infants 
aged 0-11 months (196). Additionally, a recent study suggested that enteroaggregative E. 
coli (EAEC) may be the leading cause of diarrheagenic E. coli associated food and water-
borne enteric infection in South Africa by assessing 205 E. coli strains isolated from 
producer distributor bulk milk, irrigation water, irrigated lettuce and street vendor 
coleslaw (246).  
A total of 70 good-quality MAGs were identified as E. coli (>95% ANI to known 
E. coli genomes) and represented 14 distinct strains (<99% ANI among the strains). The 
abundance of these MAGs was higher in the 1-11 months (median of 0.02; IQR, 0.005 to 
0.053 GEs) and 12-23 months (median of 0.05; IQR, 0.005 to 0.17) groups compared to 
the 24-48 months group (median of 0.00002; IQR, 0 to 0.003 GEs) (Padj of < 0.05, 
Dunn’s post-hoc test) (Figure 4-5B) and other measured variables than age did not 
significantly explain this difference in abundance (P value of  > 0.05, Kruskal-Wallis 
test). Individual E. coli strain showed, in general, similar abundance patterns to the total 
E. coli  (data not shown here); thus, the abundance of each of the 14 strains of E. coli was 
also not affected by sanitation intervention (P value of  > 0.05, Kruskal-Wallis test). 
Phylogenetic placement of all orthologous genes for the 14 strains and reference E. coli 
strains revealed several clusters (Figure 4-5A). Interestingly, four strains clustered 
together with E. coli O44:H18 strain 042, an EAEC epidemic strain (Figure 4-5A). 
Except for one strain (Map4bin002), which was recovered from a baseline intervention 
sample (i.e., prior to the exposure of sanitation intervention), three other strains (i.e., 
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Map48bin004, Map50bin014, and Map49bin008) were recovered from the sanitation 
intervention group. However, all four strains (i.e., Map4bin002, Map48bin004, 
Map50bin014, and Map49bin008) showed, more or less, similar abundances between the 
sanitation intervention and the control groups, consistent with the total E. coli populations 
data (P value of  > 0.05, Kruskal-Wallis test), as mentioned the above.  
 In order to investigate more closely the pathogenic potential of the recovered E. 
coli MAGs, we collected several diagnostic virulence genes of E. coli (Table C 5) and 
compare their presence/absence and relative abundance between the control and the 
sanitation intervention groups. 48 samples out of 79 samples showed a positive signal of 
ETEC and this was the most prevalent among the five known pathotypes included in our 
analysis. Only two variables, age and diarrhea, were strongly influenced the abundance of 
the ETEC diagnostic genes (P value of  < 0.05, Kruskal-Wallis test). Interestingly, we 
found that the diarrhea group (median of 0.003; IQR, 0.0009 to 0.006 GEs) showed a 
higher abundance of ETEC diagnostic genes compared to the non-diarrhea group (median 
of 0.00005; IQR, 0 to 0.003 GEs) (P value of  < 0.05, Kruskal-Wallis test) (Figure 4-5C). 
This result is in agreement with previous studies that ETEC is one of the important 
causative agents of diarrhea-associated morbidity and mortality among children of age 
five or younger (196, 247). However, sanitation intervention was not strongly associated 
with the prevalence of ETEC in Mozambican children. The abundance of the diagnostic 
genefor typical EPEC (i.e., bfpA, Table C 5) was associated with the sanitation 
intervention and were, in fact, higher in the sanitation intervention group (median of  0; 
IQR, 0 to 0 GEs) compared to the control group (median of  0; IQR, 0 to 0 GEs) (P value 
of  < 0.05, Kruskal-Wallis test), while the abundance of other diagnostic genes were not 
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significantly associated with sanitation intervention (P value of  > 0.05, Kruskal-Wallis 
test). It is important to note, however, that only five of samples in the intervention group 
showed a positive signal for typical EPEC, while the remaining 74 samples showed zero 
abundance, which indicated that the results obtained may be heavily influenced by a 
relative small number of individuals sampled. In the case of EAEC, the same MAGs (at 
99% ANI level) was recovered from several samples in the sanitation intervention group, 
and the abundance of EAEC diagnostic genes was slightly higher in the sanitation 
intervention group (median of 0; IQR, 0 to 0.00006 GEs) compared to the control group 
(median of 0; IQR, 0 to 0 GEs) but this difference was not statistically significant (P 
value of  ~ 0.07, Kruskal-Wallis test). Additionally, the abundance of all diagnostic genes 
was not strongly correlated with diarrhea except for the ETEC diagnostic genes (P value 
of  > 0.05, Kruskal-Wallis test). These results suggested that the sanitation intervention 
did not significantly affect the abundance of the major E. coli pathotype groups (i.e., 
ETEC, typical and atypical EPEC, EAEC, DAEC, and EHEC) and that E. coli relative 




Figure 4-5. Escherichia coli MAGs in gut microbiota of Mozambican children. (A) 
Phylogenetic tree of E. coli orthologous genes. The unus genome-based, which is the 
collection of orthologus groups present in single copy in all genomes, phylogeny of E. 
coli MAGs and selected reference genomes are shown, including commensal (HS 
commensal, CP000802.1 strain HS; O150H5SE15 commensal, AP009378.1 strain 
SE15; O152H28SE11 commensal, AP009240.1 strains SE11; O81ED1a commensal, 
CU928162.2 strain ED1a), pathogenic (0127H6E234869 EPEC, FM180568.1 strain 
0127:H6 E2348/69; 4608 EIEC, gi|735003713|gb|JTCO01000001.1| strain 4608-58 
4608-58_c1; 55989 EAEC, gi|218350208|emb|CU928145.2| strain 55989; M4163 EIEC, 
gi|735003727|gb|JTCN01000001.1| strain M4163 M4163_c1; O103H2 EHEC, 
AP010958.1 strain O103:H2 str. 12009; O139H28E24377A ETEC, CP000800.1 strain 
E24377A; O157H7EDL933 EHEC, gi|749302083|ref|NZ_CP008957.1| strain O157:H7 
str. EDL933; O18K1H7UTI89 UPEC, CP000243.1 strain UTI89; O26H1111368 
EHEC, AP010953.1 strain O26:H11 str. 11368; O44H18042 EAEC, 
gi|284919779|emb|FN554766.1| strain 042; O55H7CB9615 EPEC, CP001846.1 strain 
O55:H7 CB9615; O55H7RM12579 EPEC, CP003109.1 strain O55:H7 RM12579; 
O6K2H1CFT073 UPEC, AE014075.1 strain CFT073; O78H11K80H10407 ETEC, 
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FN649414.1 strain ETEC H10407; RS218 NMEC, CP007149.1 strain RS218; SK1144 
DAEC, NZ_AP018784.1 strain SK1144), and environmental strains (SMS35, 
gi|170517292|gb|CP000970.1| strain SMS-3-5; TW15838, 
gi|329753645|gb|AEJX01000001.1| E. sp. TW15838). (B) The abundance of E. coli 
MAGs in multiple age groups. (C) Higher abundance of ETEC diagnostic genes in the 
diarrhea group compared to the non-diarrhea group.  
4.5 Conclusions and outlook 
 In this study, we applied a shotgun sequencing approach and associated 
bioinformatic pipelines to examine the effect of several environmental and health-related 
variables on the gut microbiome composition of children under 48 months old in a low-
income, urban neighborhood in Maputo, Mozambique. Our major findings suggested that 
the dynamics of gut microbial community diversities (i.e., both α- and β-diversity), ARG 
abundance and VF abundance were mostly influenced by age group, and secondarily by 
sanitation or diarrheal status. Consistently, we were able to identify only a few species 
and gene functions that were differentially abundant between the sanitation intervention 
and the control group. Most notably, the higher abundance of V. parvula in the control vs. 
the sanitation intervention groups and in the diarrhea vs. the non-diarrhea groups, and the 
higher abundance of a few commensal taxa such as B. thetaiotaomicron in the sanitation 
intervention group were observed. Considering that V. parvula has been implicated as a 
pathogen in various infections including bacterial vaginosis in human, this species might 
be a potential biomarker for assessing health in Mozambican children.  
 It should be noted that there were several limitations in our study that might have 
affected our results and conclusions. Most notably, all participating households that had 
access to the shared sanitation facility without safe excreta management, which is a key 
criterion used in assessing eligibility for the MapSan trial (48). In such settings, we 
expected to see high exposure from various sources (soil, water, person-to-person 
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contact) that can mask the effect of sanitation intervention. Moreover, in this set of 
samples, only 1-11 months old children in the sanitation intervention group were exposed 
to the improved sanitation facilities for their entire lifetime, while the other two older-age 
groups, i.e., 12-23 months and 24-48 months, had been exposed to the poor sanitation at 
the early stage of their life (followed by sanitation intervention that last ~11 months). It is 
thus possible that these older children had been colonized by certain pathogens during 
their early life (when they did not experience sanitation intervention), resulting in 
potential health problems and long-term pathogen colonization Furthemore, the number 
of samples analyzed here is still limited; future efforts should try to expand on the 
children sampled and the duration that the children experience sanitation interventions 
(196).  
 Overall, it appears that the sanitation intervention employed in this study might 
have a significant effect on reducing health risks in Mozambican children but the effect is 
still rather minor and maybe longer sampling times or proper sets of samples, e.g., 
children exposed to sanitation interventions for their whole life time, are needed to more 
robustly quantify the effect. Furthermore, the commensal taxa recovered here might have 
important (unknown) roles in the gut microbiome functioning related to sanitation 
intervention, which should be subject of future research. 
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APPENDIX A SUPPLEMENTARY MATERIAL FOR CHAPTER 2 
A.1 Supporting results and discussion 
A.1.1 Integrative and conjugative elements (ICEs) 
 In contrast to plasmids, ICEs can be integrated into the host chromosome via 
phage integrase-mediated chromosomal integration at specific sites encoding tRNA genes 
(248). In GI-2, we found a tyrosine-based site-specific recombinase CMGI-2, and a 
tRNAGly, which was located 80 bp upstream of GI-2 and overlapped, over 22bp, with a 
sequence that was duplicated at the other end of GI-2 (Figure A 3). These results 
suggested that tyrosine-based recombinase might have catalyzed the site-specific 
integration of GI-2 in P. aeruginosa DPB. However, GI-2 also harbored a transposase 
DDE domain protein, which is known to employ various mechanisms of recombination 
with promiscuous integration sites (249), indicating that non-site-specific integration is 
also possible for this ICE. Furthermore, the presence of plasmid replication initiator 
(repA) in GI-2 suggested that GI-2 may be also prone to plasmid-like replication, similar 
to several other known ICEs (250), which blur the line dividing ICEs and conjugative 
plasmids.  
A.1.2 BAC-adaptation in P. aeruginosa 
 In contrast to all P. aeruginosa DP BAC(+) populations, P. aeruginosa DPB 
BAC(+) and BAC(-) populations did not showed higher MIC to the membrane-active 
antibiotic polymyxin B except for DPB BAC(+)_1 compared to the ancestor even 
thought they all had mutations in pmrB, albeit at different locations than DP BAC(+) 
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(Table 2-2 and Table A 3B). The mutations to pmrB in DPB BAC(+) and BAC(-) 
populations apparently did not affect their polymyxin B resistance level relative to their 
ancestor (but only their BAC tolerance level) because the level of polymyxin resistance 
depends on the type of mutation in pmrB (e.g., exact location and combinations of 
mutation) and possibility of presence of other determinants for resistance phenotype 
(137). For instance, repeated passages without polymyxin in the growth media results in 
loss of resistance in some cases, suggesting that the pmrAB locus is not the only 
determinant of the resistance phenotype (137). These other (unknown) determinants and 
their epistatic effects on the mutation on the pmrB gene presumably accounted for the 
lack of increased polymyxin B resistance in DPB BAC(+) populations. Consistent with 
these interpretations, we found that the expression level of arnBCADTEF operon under 
BAC-free (but not under BAC-exposed) conditions in all DPB BAC(+) populations was 
not significantly different from that of their ancestor, and almost no expression of arnE 
and arnF (Table A 6A). However, when BAC was added to the growth media before 
taking the sample for transcriptomics, overexpression of arnBCADT and almost no 
expression of arnE and arnF were observed (Table A 6B). arnE and arnF are 
presumably responsible for transportation of undecaprenyl phosphate-α-L-Ara4N from 
inner membrane to outer surface (138), which is required for the last step of the synthesis 
of L-Ara4N modified lipidA. Therefore, it appears that, at least in P. aeruginosa DPB, 
overexpression of arnBCAD produces undecaprenyl phosphate-α-L-Ara4N in the inner 
membrane, which is important for increased BAC tolerance but not relevant for 
conferring polymyxin B resistance; the latter apparently requires the transportation of the 
undecaprenyl phosphate-α-L-Ara4N to the outer membrane. And, incomplete expression 
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of arnBCADTEF operon, especially arnE and arnF, presumably accounted for the fact 
that DPB BAC(+) populations did not show increased polymyxin B resistance under 
BAC exposed condition compared to their ancestor (Table A 3C). Consistent with these 
findings and interpretations, the DPB BAC(-)_1 population, which showed decreased 
BAC tolerance relative to the other two P. aeurginosa DPB BAC(-) replicate populations, 
had 20bp insertion mutation in pmrA, and consequently the expression level of 
arnBCADTEF operon was not different from that of ancestor or control under the BAC-
exposed condition (Table A 4D and Table A 6C). 
 All P. aeruginosa DP BAC(-) populations showed loss of polymyxin B resistance 
relative to DP BAC(+) populations even though they had fixed mutations in pmrB 
(Figure 2-3A and Table 2-2). Read alignment of DP BAC(-) datasets against assembled 
contigs of P. aeruginosa DP ancestor suggested that subpopulations of P. aeruginosa DP 
BAC(-)_2 and DP BAC(-)_3 had different mutations in pmrB and pmrA compared to 
those in P. aeruginosa DP BAC(+) populations (Table A 5). This finding may explain 
the loss of polymyxin B resistance in these populations since the location and 
combination of mutations in pmrB are known to affect the level of polymyxin B 
resistance (discussed above). In the case of population P. aeruginosa DP BAC(-)_1, 
which did not have the mutations in pmrB or pmrA that P. aeruginosa DP BAC(-)_2 and 
BAC(-)_3 had, it is likely that mutations elsewhere in the genome during the BAC(-) 
phase were responsible for loss of polymyxin B resistance. For instance, this population 
uniquely had a 15bp insertion mutation in the quorum sensing regulator gene lasR (Table 
A 4C). Expression of more than 300 genes, including MFS transporters, RND efflux 
pump genes, and two-component response regulators, are regulated by two acyl-
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homoserine lactone systems, LasR-LasI and RhlR-RhlI (166, 167). Therefore, it is likely 
that the mutation in lasR might have induced expression changes in the genes related to 
polymyxin B resistance in P. aeruginosa BAC(-)_1 population, although this hypothesis 
awaits experimental validation. In summary, BAC exposure selected for the mutations in 
pmrB that conferred increased BAC-tolerance in all P. aeruginosa populations, but only 
specific mutations conferred increased polymyxin resistance in the DP (but not the DPB) 
genetic background. For the remaining of mutations, gene expression data provided 
testable hypotheses for explaining the lack of increased polymyxin B resistance. 
A.2 Supplementary figures and tables 
 
Figure A 1. Bioreactor development and adaptive evolution experiment. 
(A) Bioreactors were built with a microbial community inoculum 
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originating from a river sediment (Calcasieu River, USA). The substrates 
and community ages for each bioreactor are shown. Colors represent the 
abundant community members, making >1% of the total (see figure key). 
(B) Schematic representation of the adaptive evolution experimental 
design. 1% aliquot from the culture that showed a ratio higher than 0.2 of 
relative growth compared to the control (measured by optical density; 
red test tubes) for the highest concentration of BAC tested was used as 
inoculum for the next round with higher BAC concentrations. Yellow 











Figure A 2. Fragment recruitment plots of reads of isolate genomes against the P. 
aeruginosa strain DPB GI-2 reference sequence. The fragment recruitment plot 
consists of four panels: (1) Bottom left panel represents the individual reads recruited 
against GI-2, placed by location (x-axis) and percent of identity (y-axis) to GI-2 
sequence; (2) Top left panel represents sequencing depth across the reference GI-2 
sequence, i.e., number of times each nucleotide base of the reference is covered by reads, 
in logarithmic scale; (3) Bottom right panel represents identity histogram of mapping 
reads, i.e., how many bases are found at each value of nucleotide identity, in logarithmic 
scale; and (4) Top right panel represents color scale for the number of stacked reads in 
bottom left panel. Panels represent reads from: (A) K. michiganensis DPB, (B) 




Figure A 3. Schematic representation of the region where the GI-2 element was 
integrated in the P. aeruginosa DPB genome. The yellow arrow indicates the sequence 
of the tRNAGly gene. The black rectangles indicate identical short repeated sequences (22 
bp) that most likely belong to the attB integration site i.e., red-colored nucleotide bases 
are 100% identical to the tRNA gene while the blue ones do not match the tRNA gene 
sequence.   
Table A 1. Gene content of GI-2.  
The table can be found through 
https://aem.asm.org/content/84/17/e01201-18/figures-only#fig-data-
additional-files (Table S1) 
 
Table A 2. MIC values of transformants carrying efflux pump genes 
Strain 
MIC, mg/L 
BAC Tetracycline Rifampin 
PA0509-PBBRMCS4 12.5 0.2 12.5 
PA0509/pBBRsugE-A* 25 0.2 12.5 
PA0509/pBBRsugE-B 12.5 0.2 12.5 
PA0509/pBBRABC 12.5 0.2 25 
* PA0509/pBBRsugE-A showed 89.65% reduction in growth at 12.5 mg of BAC/L only 
once out of three independent replicates. The other two replicates showed ≤ 80% growth 
reduction at 12.5 mg of BAC/L and ≥ 80% reduction in growth at 25 mg of BAC/L. 
Hence, 25 mg/L is reported in the Table for BAC. 
…... …... 
GI-2 






Table A 3. MIC of antibiotics for P. aeruginosa DP & DPB evolved populations. (A) MIC of antibiotics in P.aeruginosa DP. (B) 





Tetracycline Ciprofloxacin Chloramphenicol Kanamycin Rifampin Ampicillin 
P. aeruginosa DP 
BAC(+)_1 12.5 0.4 25 > 400 25 3200 
P. aeruginosa DP 
BAC(+)_2 12.5 < 0.1 25 50 6.25 400 
P. aeruginosa DP 
BAC(+)_3 12.5 < 0.1 50 100 25 1600 
P. aeruginosa DP 
Control_1 6.25 < 0.1 50 100 25 1600 
P. aeruginosa DP 
BAC(-)_1 6.25 0.025 < 12.5 400 6.25 6400 
P. aeruginosa DP 
BAC(-)_2 3.2 0.1 25 100 < 3.2 100 
P. aeruginosa DP 
BAC(-)_3 12.5 0.8 200 200 12.5 3200 
P. aeruginosa DP 
ancestor 12.5 0.1 50 100 12.5 3200 
P. aeruginosa DP 







Tetracycline Ciprofloxacin Chloramphenicol Polymyxin B Kanamycin Rifampin Ampicillin 
P. aeruginosa DPB 
BAC(+)_1 12.5 0.2 50 0.8 200 25 12800 
P. aeruginosa DPB 
BAC(+)_2 3.125 0.2 25 0.2 50 6.25 400 
P. aeruginosa DPB 
BAC(+)_3 12.5 0.2 50 0.4 100 25 3200 
P. aeruginosa DPB 
BAC(-)_1 6.25 < 0.1 50 0.4 200 25 6400 
P. aeruginosa DPB 
BAC(-)_2 6.25 0.1 12.5 0.4 50 12.5 < 200 
P. aeruginosa DPB 
BAC(-)_3 12.5 0.2 50 0.4 100 25 1600 
P. aeruginosa DPB 
ancestor 6.25 0.2 100 0.2 100 25 3200 
P. aeruginosa DPB 
Control_1 12.5 0.4 100 0.4 100 25 3200 
P. aeruginosa DPB 
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Table A 4. (A) Details of SNP mutations in P. aeruginosa DP evolved populations. The table can be found through 
https://aem.asm.org/content/84/17/e01201-18/figures-only#fig-data-additional-files (Table S4A) 
 
(B) Details of SNP mutations in P. aeruginosa DPB evolved populations. The table can be found through 




(C) Details of DIP (deletion, insertion and other polymorphisms) mutations in P. aeruginosa DP evolved populations.  The table 




(D) Details of DIP (deletion, insertion and other polymorphisms) mutations in P. aeruginosa DPB evolved populations. The 




Table A 5. Subpopulational mutations in pmrB and pmrA in P. aeruginosa DP BAC(-) populations (Breseq polymorphism 
mode). 
 












Cont53 pmrA 10,036 G→C L(ancestor and BAC(+)_2) 59 V(BAC(-)_2) 26.80% 
pmrB 8,872 Δ7 bp   7.10% 




















Table A 6. (A) Mean transcript abundance and log2 fold change of 
arnBCADTEF under BAC free condition (only LB) in P. aeruginosa DPB 
populations. AL: P. aeruginosa DPB ancestor in LB growth media; C2L: 
P. aeruginosa DPB_Control_2 in LB; BAC(+)_1L: P. aeruginosa 
DPB_BAC(+)_1 in LB; BAC(+)_2L: P. aeruginosa DPB BAC(+)_2 in LB; 
BAC(+)_3L: P. aeruginosa DPB BAC(+)_3 in LB.   
AL_vs_C2L 
 log2FoldChange lfcSE baseMean padj 
arnB -0.19 0.465671379 2881.36 0.95 
arnC -0.39 0.47302977 1451.45 0.86 
arnA -0.42 0.500156202 1981.62 0.85 
arnD -0.13 0.501352141 46.85 0.97 
arnT (partial) -0.13 0.442507489 41.99 0.97 
arnT (partial) -0.33 0.49133792 7.30 0.91 
arnE -0.52 0.404176235 0.62 NA 
arnF -0.95 0.492629556 0.91 NA 
AL_vs_BAC(+)_1L 
 log2FoldChange lfcSE baseMean padj 
arnB -0.73 0.431743475 2405.79 0.53 
arnC -1.13 0.472772597 1175.81 0.18 
arnA -0.59 0.504809163 1886.49 0.78 
arnD 0.10 0.554740919 52.12 0.99 
arnT (partial) 1.01 0.519615554 75.69 0.39 
arnT (partial) 1.12 0.524817195 15.96 0.29 
arnE 0.30 0.618855137 1.57 NA 
arnF 1.04 0.612313641 3.52 0.53 
AL_vs_BAC(+)_2L 
 log2FoldChange lfcSE baseMean padj 
arnB 0.32 0.533642396 3428.44 0.91 
arnC -0.58 0.569188667 1415.15 0.81 
arnA -0.55 0.570356139 1988.36 0.82 
arnD 0.18 0.594907641 52.14 0.97 
arnT (partial) 0.58 0.540764554 53.92 0.78 
arnT (partial) 0.82 0.584488374 11.75 0.63 
arnE 0.01 0.693819434 1.24 1.00 
arnF -1.07 0.71890835 1.07 0.60 
AL_vs_BAC(+)_3L 
 log2FoldChange lfcSE baseMean padj 
arnB 0.46 0.452365733 3609.00 0.60 
arnC 0.27 0.482877747 1820.99 0.81 
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arnA 0.73 0.506073653 3138.40 0.41 
arnD 1.91 0.517494933 128.36 0.00 
arnT (partial) 2.24 0.432234197 134.41 0.00 
arnT (partial) 2.70 0.456141305 36.24 0.00 
arnE 1.20 0.809027602 2.77 0.39 
arnF 1.38 0.728107695 3.82 0.23 
 
 
(B) Mean transcript abundance and log2 fold change of arnBCADTEF under BAC 
exposure (LB+BAC) in P. aeruginosa DPB populations. AB: P. aeruginosa DPB 
ancestor in LB+BAC media; C2B: P. aeruginosa DPB Control_2 in LB+BAC; 
BAC(+)_1B: P. aeruginosa DPB BAC(+)_1 in LB+BAC; BAC(+)_2B: P. aeruginosa 
DPB BAC(+)_2 in LB+BAC; BAC(+)_3B: P. aeruginosa DPB BAC(+)_3 in LB+BAC. 
 
AB_vs_C2B 
 log2FoldChange lfcSE baseMean padj 
arnB 0.09 0.215104554 801.92 1.00 
arnC 0.12 0.23495053 550.45 1.00 
arnA 0.01 0.207432747 1599.01 1.00 
arnD -0.20 0.327154778 43.52 1.00 
arnT (partial) -0.01 0.302074495 67.17 1.00 
arnT (partial) -0.59 0.415935123 12.70 0.84 
arnE 0.31 0.404163246 0.97 NA 
arnF 0.12 0.453587471 1.20 NA 
AB_vs_BAC(+)_1B 
 log2FoldChange lfcSE baseMean padj 
arnB 1.28 0.23754236 1160.45 0.00 
arnC 1.36 0.269060725 824.93 0.00 
arnA 1.45 0.224670717 2606.73 0.00 
arnD 1.14 0.31840902 65.64 0.00 
arnT (partial) 1.79 0.304537468 134.99 0.00 
arnT (partial) 0.79 0.435402146 19.35 0.24 
arnE 0.49 0.730632955 0.87 NA 
arnF 1.48 0.727945525 2.56 NA 
AB_vs_BAC(+)_2B 
 log2FoldChange lfcSE baseMean padj 
arnB 1.00 0.294281292 1088.14 0.01 
arnC 1.24 0.236915578 825.38 0.00 
arnA 1.14 0.297513844 2395.02 0.00 
arnD 1.07 0.395549988 69.30 0.05 
arnT (partial) 1.61 0.315054698 130.25 0.00 
arnT (partial) 0.56 0.396600845 18.63 0.45 
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arnE -0.13 0.586931586 0.37 NA 
arnF 0.82 0.73034847 1.74 0.59 
AB_vs_BAC(+)_3B 
 log2FoldChange lfcSE baseMean padj 
arnB 2.90 0.21317264 2516.05 0.00 
arnC 3.15 0.195491069 1989.37 0.00 
arnA 2.83 0.216985234 4967.34 0.00 
arnD 2.72 0.250158093 136.69 0.00 
arnT (partial) 2.88 0.241083376 218.91 0.00 
arnT (partial) 1.94 0.368403034 30.47 0.00 
arnE 1.84 0.828393669 1.90 NA 
arnF 2.22 0.767476884 3.86 0.02 
 
Table A 7. Statistics of RNA-seq libraries. The table can be found 
through https://aem.asm.org/content/84/17/e01201-18/figures-only#fig-
























APPENDIX B SUPPLEMENTARY MATERIAL FOR CHAPTER 3 
B.1 Supplementary figures and tables 
 
Table B 1. (A) Details of SNP mutations found in P. aeruginosa DP evolved 
populations. The table can be found through https://aem.asm.org/content/84/12/e00197-
18/figures-only#fig-data-additional-files (Table S1A) 
 
(B) Details of SNP mutations in P. aeruginosa DPB evolved populations. 
The table can be found through 
https://aem.asm.org/content/84/12/e00197-18/figures-only#fig-data-
additional-files (Table S1B) 
(C) Details of DIP (deletion, insertion and other polymorphisms) 
mutations detected in P. aeruginosa DP evolved populations. The table 
can be found through https://aem.asm.org/content/84/12/e00197-
18/figures-only#fig-data-additional-files (Table S1C) 
(D) Details of DIP (deletion, insertion and other polymorphisms) mutations detected 




(E) Mutations in pmrB and pmrA genes found in P. aeruginosa DP BAC(-) 




Table B 2.   




Table B 3. 
The table can be found through https://aem.asm.org/content/84/12/e00197-18/figures-
only#fig-data-additional-files (Table S3) 
 
Table B 4. 
The table can be found through https://aem.asm.org/content/84/12/e00197-18/figures-
only#fig-data-additional-files (Table S4) 
 
Table B 5. 
The table can be found through https://aem.asm.org/content/84/12/e00197-18/figures-
only#fig-data-additional-files (Table S5) 
 
Table B 6. 
The table can be found through https://aem.asm.org/content/84/12/e00197-18/figures-
only#fig-data-additional-files (Table S6) 
 
Table B 7.  
The table can be found through https://aem.asm.org/content/84/12/e00197-18/figures-
only#fig-data-additional-files (Table S7) 
 
Table B 8. 
The table can be found through https://aem.asm.org/content/84/12/e00197-18/figures-














APPENDIX C SUPPLEMENTARY MATERIAL FOR CHAPTER 4 
C.1 Supplementary figures and tables 
Table C 1. Taxonomic classification of recovered MAGs. The Microbial 
Genome Atlas (MiGA) webserver was used to determine the most likely 
taxonomic classification of MAGs against the classified species in NCBI’s 
prokaryotic genome database (222). 





Map_49_maxbin_001 ANIsp_2 Prevotella_jejuni_CP023863 62.19 




Map_67_maxbin_001 ANIsp_5 Roseburia_hominis_A2_183_NC_015977 41.96 







Map_41_maxbin_004 ANIsp_9 Bacteroides_fragilis_NZ_LN877293 98.24 




Map_109_maxbin_010 ANIsp_12 Dialister_pneumosintes_NZ_CP017037 56.18 
Map_9_maxbin_004 ANIsp_13 Bifidobacterium_breve_CP021387 98.07 




Map_113_maxbin_021 ANIsp_16 Libanicoccus_massiliensis_NZ_LT671675 65.73 







Map_91_maxbin_009 ANIsp_20 Prevotella_enoeca_NZ_CP013195 61.53 
Map_30_maxbin_015 ANIsp_21 Megamonas_hypermegale_NZ_LT906446 80.22 
Map_100_maxbin_009 ANIsp_22 Pasteurella_multocida_CP023304 47.25 
 
 119 
Map_14_maxbin_019 ANIsp_23 Bacteroides_vulgatus_NZ_CP013020 56.43 




Map_114_maxbin_012 ANIsp_26 Bacteroides_vulgatus_NZ_CP013020 56.79 
Map_51_maxbin_007 ANIsp_27 Muribaculum_intestinale_NZ_CP021421 56.49 







Map_23_maxbin_012 ANIsp_31 Streptococcus_sp__HSISS3_CM002130 96.72 




Map_96_maxbin_002 ANIsp_34 Prevotella_jejuni_CP023863 60.63 














Map_24_maxbin_011 ANIsp_41 Prevotella_enoeca_NZ_CP013195 61.79 
Map_10_maxbin_003 ANIsp_42 Veillonella_parvula_NZ_CP019721 90.93 
























































Map_3_maxbin_005 ANIsp_65 Prevotella_enoeca_NZ_CP013195 62.38 



































Map_85_maxbin_025 ANIsp_80 Streptococcus_salivarius_NZ_CP015282 97.01 




Map_102_maxbin_014 ANIsp_82 Collinsella_aerofaciens_NZ_CP024160 41.64 
Map_102_maxbin_017 ANIsp_83 Roseburia_intestinalis_M50_1_FP929049 53.55 
Map_102_maxbin_022 ANIsp_84 Blautia_coccoides_NZ_CP022713 68.02 







Map_104_maxbin_012 ANIsp_88 Dialister_pneumosintes_NZ_CP017037 56.06 




Map_105_maxbin_033 ANIsp_91 Acutalibacter_muris_NZ_CP021422 50.74 
Map_107_maxbin_018 ANIsp_92 Dialister_pneumosintes_NZ_CP017037 56.08 
Map_110_maxbin_009 ANIsp_93 Paeniclostridium_sordellii_CP014150 40.50 




Map_115_maxbin_017 ANIsp_96 Roseburia_intestinalis_M50_1_FP929049 53.33 
Map_115_maxbin_030 ANIsp_97 _Clostridium__cellulosi_NZ_LM995447 47.36 

























































Map_54_maxbin_004 ANIsp_120 Blautia_obeum_A2_162_FP929054 67.20 




Map_57_maxbin_008 ANIsp_123 Collinsella_aerofaciens_NZ_CP024160 88.10 
Map_57_maxbin_013 ANIsp_124 Akkermansia_muciniphila_NZ_CP021420 88.65 
Map_58_maxbin_008 ANIsp_125 Flavonifractor_plautii_NZ_CP015406 49.35 
Map_58_maxbin_015 ANIsp_126 Clostridium__bolteae_NZ_CP022464 64.70 
Map_58_maxbin_020 ANIsp_127 Clostridium_chauvoei_NZ_CP018624 63.78 











Map_69_maxbin_011 ANIsp_133 Bacteroides_vulgatus_NZ_CP013020 56.34 

















Map_81_maxbin_026 ANIsp_141 Dialister_pneumosintes_NZ_CP017037 56.03 












Map_8_maxbin_008 ANIsp_146 Odoribacter_splanchnicus_NZ_LT906459 98.04 
Map_92_maxbin_013 ANIsp_147 Prevotella_jejuni_CP023863 59.72 











Map_9_maxbin_003 ANIsp_153 Klebsiella_pneumoniae_CP011421 99.10 
 
Table C 2. Permutational multivariate analysis of variance 
(PERMANOVA) tests of metadata and Mash distances among samples 
(permutation = 999, Significance codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 
0.1 ‘ ’ 1). 
Metadata R2 Pr(>F) sig 
age_sampCat 0.31518 0.001 *** 
Studyarm_binary 0.01239 0.184  
female 0.01246 0.181  
Compound_sanitary_index 0.0145 0.127  
Ppl_per_Hhroom_categorical 0.01755 0.077 . 
HL_populationdensity_quintiles 0.01357 0.156  
chronpain 0.01092 0.257  
diarrhea 0.02274 0.042 * 
age_sampCat:Studyarm_binary 0.02186 0.243  
age_sampCat:female 0.01969 0.292  
Studyarm_binary:female 0.01628 0.103  
age_sampCat:Compound_sanitary_index 0.02222 0.236  
Studyarm_binary:Compound_sanitary_index 0.00617 0.54  
female:Compound_sanitary_index -0.003 0.999  
age_sampCat:Ppl_per_Hhroom_categorical 0.01443 0.488  
Studyarm_binary:Ppl_per_Hhroom_categorical 0.00666 0.494  
female:Ppl_per_Hhroom_categorical 0.00445 0.714  
Compound_sanitary_index:Ppl_per_Hhroom_categorical 0.00223 0.914  
age_sampCat:HL_populationdensity_quintiles 0.01102 0.693  
Studyarm_binary:HL_populationdensity_quintiles 0.01162 0.233  
female:HL_populationdensity_quintiles 0.00344 0.804  
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Compound_sanitary_index:HL_populationdensity_quintiles 0.00329 0.837  
Ppl_per_Hhroom_categorical:HL_populationdensity_quintiles 0.01073 0.254  
age_sampCat:chronpain 0.01488 0.508  
Studyarm_binary:chronpain 0.0054 0.629  
female:chronpain 0.00983 0.259  
age_sampCat:diarrhea 0.0114 0.652  
Studyarm_binary:diarrhea 0.00517 0.654  
female:diarrhea 0.00313 0.841  
Compound_sanitary_index:diarrhea 0.02775 0.017 * 
Ppl_per_Hhroom_categorical:diarrhea 0.01193 0.191  
HL_populationdensity_quintiles:diarrhea 0.00773 0.435  
age_sampCat:Studyarm_binary:female 0.01019 0.75  
age_sampCat:Studyarm_binary:Compound_sanitary_index 0.03359 0.056 . 
age_sampCat:female:Compound_sanitary_index 0.01511 0.472  
Studyarm_binary:female:Compound_sanitary_index 0.0059 0.604  
age_sampCat:Studyarm_binary:Ppl_per_Hhroom_categorical 0.01185 0.21  
age_sampCat:female:Ppl_per_Hhroom_categorical 0.00493 0.658  
Studyarm_binary:female:Ppl_per_Hhroom_categorical 0.00972 0.306  
age_sampCat:Compound_sanitary_index:Ppl_per_Hhroom_cat
egorical 0.02757 0.119  
Studyarm_binary:Compound_sanitary_index:Ppl_per_Hhroom
_categorical 0.00859 0.369  
female:Compound_sanitary_index:Ppl_per_Hhroom_categorica
l 0.00485 0.657  
age_sampCat:Studyarm_binary:HL_populationdensity_quintile
s 0.02184 0.056 . 
age_sampCat:female:HL_populationdensity_quintiles 0.00272 0.886  
Studyarm_binary:female:HL_populationdensity_quintiles 0.00784 0.416  
age_sampCat:Compound_sanitary_index:HL_populationdensit
y_quintiles 0.00945 0.302  
Studyarm_binary:Compound_sanitary_index:HL_populationde
nsity_quintiles 0.01211 0.193  
female:Compound_sanitary_index:HL_populationdensity_quint
iles 0.00319 0.852  
age_sampCat:Ppl_per_Hhroom_categorical:HL_populationden
sity_quintiles 0.01316 0.167  
Studyarm_binary:Ppl_per_Hhroom_categorical:HL_population
density_quintiles 0.00774 0.424  
female:Ppl_per_Hhroom_categorical:HL_populationdensity_qu
intiles 0.00346 0.8  
age_sampCat:HL_populationdensity_quintiles:diarrhea 0.01254 0.175  
age_sampCat:Studyarm_binary:Compound_sanitary_index:HL
_populationdensity_quintiles 0.01166 0.21  
age_sampCat:female:Compound_sanitary_index:HL_populatio
ndensity_quintiles 0.00589 0.564  
Residuals 0.08856   
Total 1   
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Table C 3 Permutational multivariate analysis of variance 
(PERMANOVA) tests of metadata and Mash distances among samples in 
the 1-11 months old group (permutation = 999, Significance codes:  0 
‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1). 
Metadata R2 Pr(>F) sig 
Studyarm_binary 0.04529 0.083 . 
female 0.04308 0.116  
Compound_sanitary_index 0.02693 0.445  
Ppl_per_Hhroom_categorical 0.04138 0.15  
HL_populationdensity_quintiles 0.02181 0.621  
chronpain 0.01698 0.82  
diarrhea 0.02859 0.398  
Studyarm_binary:female 0.02879 0.373  
Studyarm_binary:Compound_sanitary_index 0.04205 0.139  
female:Compound_sanitary_index 0.01406 0.911  
Studyarm_binary:Ppl_per_Hhroom_categorical 0.05145 0.054 . 
female:Ppl_per_Hhroom_categorical 0.03011 0.373  
Compound_sanitary_index:Ppl_per_Hhroom_categorical 0.02786 0.413  
Studyarm_binary:HL_populationdensity_quintiles 0.0306 0.32  
female:HL_populationdensity_quintiles 0.02339 0.556  
Compound_sanitary_index:HL_populationdensity_quintiles 0.03834 0.175  
Ppl_per_Hhroom_categorical:HL_populationdensity_quintiles 0.02841 0.393  
female:chronpain 0.02639 0.428  
Studyarm_binary:diarrhea 0.01657 0.87  
female:diarrhea 0.01231 0.953  
Ppl_per_Hhroom_categorical:diarrhea 0.03399 0.258  
HL_populationdensity_quintiles:diarrhea 0.05585 0.051 . 
Studyarm_binary:female:Compound_sanitary_index 0.01898 0.741  
Studyarm_binary:female:HL_populationdensity_quintiles 0.03368 0.258  
Studyarm_binary:Compound_sanitary_index:HL_populationde
nsity_quintiles 0.02591 0.465  
female:Compound_sanitary_index:HL_populationdensity_quint
iles 0.01803 0.792  
Residuals 0.21918   
Total 1   
 
Table C 4 Permutational multivariate analysis of variance 
(PERMANOVA) tests of metadata and Mash distances among samples in 
the 24-48 months old group (permutation = 999, Significance codes:  0 
‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1). 
Metadata R2 Pr(>F) sig 
Studyarm_binary 0.0406 0.071 . 
female 0.0359 0.122  
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Compound_sanitary_index 0.04438 0.044 * 
Ppl_per_Hhroom_categorical 0.06091 0.002 ** 
HL_populationdensity_quintiles 0.05438 0.008 ** 
chronpain 0.0216 0.715  
diarrhea 0.04822 0.023 * 
Studyarm_binary:female 0.03545 0.139  
Studyarm_binary:Compound_sanitary_index 0.04315 0.053 . 
female:Compound_sanitary_index 0.03149 0.222  
Studyarm_binary:Ppl_per_Hhroom_categorical 0.018 0.858  
female:Ppl_per_Hhroom_categorical 0.02854 0.36  
Compound_sanitary_index:Ppl_per_Hhroom_categorical 0.03526 0.135  
Studyarm_binary:HL_populationdensity_quintiles 0.03454 0.169  
female:HL_populationdensity_quintiles 0.0293 0.33  
Compound_sanitary_index:HL_populationdensity_quintiles 0.02757 0.389  
Ppl_per_Hhroom_categorical:HL_populationdensity_quintiles 0.03391 0.153  
Studyarm_binary:diarrhea 0.04279 0.047 * 
female:diarrhea 0.02765 0.355  
HL_populationdensity_quintiles:diarrhea 0.03407 0.191  
Studyarm_binary:female:Compound_sanitary_index 0.04553 0.034 * 
Studyarm_binary:female:Ppl_per_Hhroom_categorical 0.03055 0.282  
Studyarm_binary:Compound_sanitary_index:Ppl_per_Hhroom
_categorical 0.02932 0.283  
Studyarm_binary:female:HL_populationdensity_quintiles 0.03212 0.227  
Studyarm_binary:Compound_sanitary_index:HL_populationde
nsity_quintiles 0.03326 0.202  
female:Compound_sanitary_index:HL_populationdensity_quint
iles 0.02292 0.636  
Residuals 0.0786   
Total 1   
 
Table C 5. E. coli diagnostic genes used in this study to assess virulence 
potential of recovered E. coli MAGs. 

































































































Figure C 1. Relative abundance of different classes of ARGs. deepARG 
(215) was used to identify and classify ARG-encoding metagenomic reads 












































































































































































































































































































































































































































































































































Figure C 2. (A) Higher aminoglycoside and multidrug resistance gene 
abundance in younger age groups compared to 24-48 months old group. 
(B) Higher β-lactam resistance gene abundance in male children. (C) 
Higher chloramphenicol resistance gene abundance in sanitation 














































































































































































































































































































































































































































































































































































ANIsp_001:d:Bacteria p:Proteobacteria c:Gammaproteobacteria o:Enterobacterales f:Enterobacteriaceae g:Escherichia s:Escherichia_coli
ANIsp_002:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_003:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_005:d:Bacteria p:Firmicutes c:Clostridia o:Clostridiales f:Ruminococcaceae g:Faecalibacterium s:Faecalibacterium_prausnitzii
ANIsp_004:d:Bacteria p:Actinobacteria c:Actinobacteria o:Bifidobacteriales f:Bifidobacteriaceae g:Bifidobacterium s:Bifidobacterium_longum
ANIsp_012:d:Bacteria p:Firmicutes c:Negativicutes o:Veillonellales f:Veillonellaceae
ANIsp_009:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Bacteroidaceae g:Bacteroides s:Bacteroides_fragilis
ANIsp_153:d:Bacteria p:Proteobacteria c:Gammaproteobacteria o:Enterobacterales f:Enterobacteriaceae g:Klebsiella s:Klebsiella_pneumoniae
ANIsp_007:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Bacteroidaceae g:Bacteroides s:Bacteroides_vulgatus
ANIsp_010:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_019:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_030:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Tannerellaceae g:Parabacteroides s:Parabacteroides_sp._CT06
ANIsp_014:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_031:d:Bacteria p:Firmicutes c:Bacilli o:Lactobacillales f:Streptococcaceae g:Streptococcus s:Streptococcus_sp._HSISS3
ANIsp_121:d:Bacteria p:Proteobacteria c:Gammaproteobacteria o:Enterobacterales f:Enterobacteriaceae g:Enterobacter s:Enterobacter_cloacae
ANIsp_024:d:Bacteria p:Actinobacteria c:Coriobacteriia o:Coriobacteriales f:Coriobacteriaceae g:Collinsella s:Collinsella_aerofaciens
ANIsp_011:d:Bacteria p:Actinobacteria c:Actinobacteria o:Bifidobacteriales f:Bifidobacteriaceae g:Bifidobacterium s:Bifidobacterium_bifidum
ANIsp_123:d:Bacteria p:Actinobacteria c:Coriobacteriia o:Coriobacteriales f:Coriobacteriaceae g:Collinsella
ANIsp_037:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Bacteroidaceae
ANIsp_028:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Bacteroidaceae g:Bacteroides s:Bacteroides_ovatus
ANIsp_077:d:Bacteria p:Proteobacteria c:Gammaproteobacteria o:Pasteurellales f:Pasteurellaceae g:Haemophilus s:Haemophilus_parainfluenzae
ANIsp_034:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_145:d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_006:d:Bacteria p:Firmicutes c:Negativicutes o:Veillonellales f:Veillonellaceae





Figure C 4. Two MAGs showing higher abundance of ARGs in the sanitation 
























































































































































































































































































































































































































































































































































ANIsp_003d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_002d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_001d:Bacteria p:Proteobacteria c:Gammaproteobacteria o:Enterobacterales f:Enterobacteriaceae g:Escherichia s:Escherichia_coli
ANIsp_004d:Bacteria p:Actinobacteria c:Actinobacteria o:Bifidobacteriales f:Bifidobacteriaceae g:Bifidobacterium s:Bifidobacterium_longum
ANIsp_005d:Bacteria p:Firmicutes c:Clostridia o:Clostridiales f:Ruminococcaceae g:Faecalibacterium s:Faecalibacterium_prausnitzii
ANIsp_077d:Bacteria p:Proteobacteria c:Gammaproteobacteria o:Pasteurellales f:Pasteurellaceae g:Haemophilus s:Haemophilus_parainfluenzae
ANIsp_075d:Bacteria p:Firmicutes c:Clostridia o:Clostridiales f:Ruminococcaceae
ANIsp_153d:Bacteria p:Proteobacteria c:Gammaproteobacteria o:Enterobacterales f:Enterobacteriaceae g:Klebsiella s:Klebsiella_pneumoniae
ANIsp_011d:Bacteria p:Actinobacteria c:Actinobacteria o:Bifidobacteriales f:Bifidobacteriaceae g:Bifidobacterium s:Bifidobacterium_bifidum
ANIsp_120d:Bacteria p:Firmicutes c:Clostridia o:Clostridiales f:Lachnospiraceae
ANIsp_030d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Tannerellaceae g:Parabacteroides s:Parabacteroides_sp._CT06
ANIsp_028d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Bacteroidaceae g:Bacteroides s:Bacteroides_ovatus
ANIsp_125d:Bacteria p:Firmicutes c:Clostridia
ANIsp_012d:Bacteria p:Firmicutes c:Negativicutes o:Veillonellales f:Veillonellaceae
ANIsp_024d:Bacteria p:Actinobacteria c:Coriobacteriia o:Coriobacteriales f:Coriobacteriaceae g:Collinsella s:Collinsella_aerofaciens
ANIsp_007d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Bacteroidaceae g:Bacteroides s:Bacteroides_vulgatus
ANIsp_142d:Bacteria p:Actinobacteria c:Coriobacteriia o:Coriobacteriales f:Coriobacteriaceae g:Collinsella
ANIsp_152d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Rikenellaceae g:Alistipes s:Alistipes_finegoldii
ANIsp_151d:Bacteria p:Firmicutes c:Clostridia
ANIsp_150d:Bacteria p:Firmicutes c:Clostridia o:Clostridiales f:Oscillospiraceae
ANIsp_149d:Bacteria p:Firmicutes c:Clostridia
ANIsp_148d:Bacteria p:Actinobacteria c:Coriobacteriia o:Coriobacteriales f:Coriobacteriaceae g:Collinsella
ANIsp_147d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Prevotellaceae
ANIsp_146d:Bacteria p:Bacteroidetes c:Bacteroidia o:Bacteroidales f:Odoribacteraceae g:Odoribacter s:Odoribacter_splanchnicus
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